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AIMS
The experiments described in this thesis were undertaken to  fo llow  up 
the assertion (Fine, 1954) tha t endotoxin (widely accepted as a 
contributing fac to r in the c lin ica l syndrome o f septic shock) more 
often derives from  the normal bacteria l population o f the in testine 
than from  a focus o f invading pathogens.
I f  th is were the case, i t  would fo llow  tha t the live r, constitu ting as i t  
does the channel through which endotoxin necessarily passes, should 
be pa rticu la rly  exposed to  damage. Assessment o f the extent o f such 
damage, therefore , seemed appropriate. The im mediate d iff ic u lty  
was tha t the established tests o f live r function, such as assays o f 
plasma alkaline phosphatase, aspartate transaminase, alanine 
transaminase, and gam m a-glutamyl transferase, or measurement o f 
plasma b ilirub in , while useful indicators o f live r im pairm ent fo r 
c lin ica l purposes, do not provide any quantita tive  estim ate o f the loss 
o f liv e r function. Such an estim ate could, however, be obtained by 
measurement o f clearance o f antipyrine, which is exclusively 
metabolised by the cytochrome P450 system o f the liv e r. An 
additional im portant fac to r was the e ffe c t o f endotoxin on 
d is tribu tion  o f cardiac output, w ith  pa rticu la r regard to the 
splanchnic and hepatic c ircu la tion . Measurement o f live r blood flow  
was therefore considered to  be a valuable complementary 
measurement to tha t o f antipyrine clearance. Sequential 
measurements o f both indocyanine and antipyrine clearance in the 
presence o f endotoxin should help to elucidate the role o f the la tte r  
in disturbed hepatocellular function.
The second issue addressed by these experiments was the 
in terre la tionsh ip  between hepatocellu lar and re ticu loendothe lia l 
function . F ibronectin assay was used to assess re ticu loendothe lia l 
function in sepsis and, together w ith  measurements o f cardiovascular 
and resp ira tory status, to  determ ine the e ffe c t o f restoring to  normal 
values depressed fib ronectin  levels by means o f cryoprec ip ita te  
infusion.
SUMMARY
1. A com m ercia lly available im m unoturb id im etric  assay fo r 
plasma fib ronectin  has been m odified to  improve its  sens itiv ity  to  the 
point where i t  can be used to  measure the low levels frequently 
encountered in hospital p ractice .
2. A study o f plasma fib ronectin  levels in healthy subjects 
revealed a Gaussian d is tribu tion . The mean fo r young males was 
higher than tha t fo r young females. In both sexes e lderly subjects 
showed higher levels than young subjects, but the d iffe rence in males 
was less than tha t in females, so tha t the sex d iffe rence  was 
reversed. Surgery caused a transient decrease. In add ition, a more 
sustained decrease was seen in non-survivors.
3. An investigation o f physiological and biochem ical changes in 
patients suffering from  septic shock was undertaken. I t  was found 
tha t in such patients indocyanine green clearance (which is norm ally 
regarded as an index o f hepatic blood flow ) was less than ha lf the 
normal value. There was no s ign ifican t d iffe rence in absolute values 
between patients who u ltim a te ly  survived and those who succumbed, 
but, in general, the fo rm er showed an im provement in clearance 
during the f ir s t  24 hours in Intensive Care, while the la tte r  showed a 
de terio ra tion . An tipyrine h a lf- life  (which is generally taken as an 
index o f the a c tiv ity  o f the cytochrome P450 system) was prolonged 
to  about tw ice  the normal value. Plasma fib ronectin  levels were 
invariably low on admission to  Intensive Care; consistently low or 
steadily fa lling  levels generally presaged death.
4. The levels o f plasma fib ronectin  in septic shock patients could
be restored to normal by repeated infusions o f cryoprec ip ita te . This 
trea tm en t s ign ifican tly  reduced th e ir plasma endotoxin levels and 
improved th e ir urine output. I t  appeared also to improve m o rta lity  
ra te , at least in the f ir s t  few  days o f the patients’ stay in intensive 
care. Cardiac output, pulmonary a rte ry  wedge pressure, pulmonary
vascular resistance and indocyanine green clearance were not 
s ign ifican tly  a ltered.
5. The observation tha t antipyrine h a lf- life  is extended in septic
shock was followed up by an investigation o f the e ffe c t o f 
intravenous endotoxin adm in istra tion on the cytochrome P450 system 
in the livers o f ra ts. I t  was found tha t the a c tiv itie s  o f cytochrom e 
b5, the cytochrome c reductases and cytochrome P450 its e lf  were a ll 
reduced, the reduction being greatest w ith  cytochrome P450. These 
e ffec ts  were produced at endoxotin levels fa r below those required to  
lower the blood pressure.
6. The observation tha t indocyanine green clearance is g rea tly
impaired in septic shock was followed up by infusing suspensions o f 
Escherichia co li in to  pigs. This e lic ited  the haemodynamic response 
s im ila r to tha t seen in untreated septic shock patients: cardiac
output was maintained in it ia lly  and then fe ll;  blood pressure fe ll 
gradually and progressively; tachycardia developed; and pulmonary 
vascular resistance rose sharply. Simultaneous infusion o f co llo id  at 
a level su ffic ien t to maintain le f t  a tr ia l pressure at norm al levels (a 
form  o f trea tm ent customary in septic shock) s im ila rly  produced 
e ffec ts  comparable to those seen in patients: cardiac output
increased; blood pressure was maintained in it ia lly  but then dropped;
and tachycardia was less marked than in the absence o f collo id  
adm in istra tion. Whether collo id  was infused or not, there was a rapid 
and progressive fa ll in plasma fib ronectin . Indocyanine green 
clearance was decreased by 50%, perhaps because o f im paired 
extraction  by the liv e r ra ther than diminished hepatic blood flow . 
Blood lac ta te  levels in it ia lly  tended to fa ll but towards the end o f the 
experiment rose d ram atica lly , whether collo id  was given or not.
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CHAPTER 1
INTRODUCTION
Though shock is a common c lin ica l problem, i t  defies simple 
de fin ition . Its cause is m u ltifa c to ria l, but inadequate tissue perfusion 
combined w ith  a decrease in oxygen ava ilab ility  and u tilisa tio n  are 
ubiquitous m anifestations, regardless o f the insu lt. Sepsis is now 
more frequently recognised as a cause, and a com bination o f sepsis 
and shock has an extrem ely poor prognosis* Many agents have been 
im plicated in the pathogenesis o f septic shock: G ram -positive 
bacteria , Gram-negative bacteria , fungi and viruses. The same 
c lin ica l p ic tu re  is observed regardless o f the cause, and i t  is generally 
accepted tha t the haemodynamic disturbances are m erely a 
re fle c tion  o f the underlying m etabolic derangement.
This chapter describes the history o f shock, w ith  emphasis on 
bacteraem ia. Endotoxin is examined as a causative agent and its  
e ffec ts  on metabolism are explored. The anatomy and physiology o f 
the live r are described, and three facets o f live r function  are 
considered, m icrosomal cytochrome metabolism, hepatic blood flow  
and plasma fib ronectin . F ina lly , fib ronectin  replacement is reviewed 
as a po tentia l therapy in septic shock.
H istory o f Shock
The concept o f shock can be traced back to  two unrelated reports 
published in the early eighteenth century. Hales (1733) observed th a t 
in exsanguinated animals there was venous constric tion w ith  a rise in 
venous pressure, while Le Dran (1743) described a condition whereby
the "cap illa ry  flow  choked up" fo llow ing haemorrhage caused by a 
gunshot wound. By the turn  o f the century the expression was in 
general use. Abernethy (1804) observed a patient who "sank in shock 
in consequence o f the operation". La tta  (1831) noticed many 
s im ila ritie s  in in jured patients and those suffering from  cholera, and 
suggested the involvement o f tox ic  substances in his in jured patients.
While wound in fection  had been recognised by L is te r (1867) i t  was not 
u n til the end o f the nineteenth century tha t the existence o f blood- 
borne bacteria  was demonstrated by B r ill and Libman (1899), who 
described a condition o f bacteraem ia caused by Pseudomonas 
aeruginosa. A t about the same tim e  Ranberg (1899) showed the 
existence o f "tox ic  shock" in animals in jected w ith  bacteria . Ten 
years la te r Jacob (1909) reported 39 cases o f Escherichia co li sepsis 
in humans and im plicated the b ilia ry  tra c t,  urinary tra c t and 
gastro in testina l tra c t as portals o f entry fo r bacteria .
Over the next decade much work was done to  elucidate biochem ical 
abnorm alities during shock. M cElleroy (1918) observed tha t acidosis 
was a symptom o f shock, and W right (1918) showed th a t a decreased 
blood flow  leads to  an accumulation o f acid products in the tissues. 
By the end o f the F irs t World War i t  had been documented th a t 
bacteria l in fec tion  fo llow ing a gunshot wound produced "to x in ". 
Debridement and the use o f antigangrene serum was recommended 
(Vallee 1918). Shock a fte r surgery had been described by Abernethy 
in 1824. A century la te r Fe lty  and Keefer (1924) suggested th a t 
surgery was a predisposing fa c to r in many cases o f Escherichia co li 
sepsis. Furtherm ore, they were o f the be lie f tha t the extent and 
location o f the prim ary focus, as opposed to  the mere fa c t o f sepsis,
were the major prognostic facto rs . I t  was F letcher (1947) who 
observed hypotension associated w ith  sepsis. However, Waisbren 
(1951) recognised tha t hypotension was a prom inent m anifestation o f 
severe sepsis and, in contrast to  Fe lty  and Keefe r, Waisbren 
considered tha t sepsis its e lf was a major fac to r to  be considered 
when assessing prognosis.
By this tim e C hurch ill (1951), amongst others, had realised th a t there 
were differences between septic shock and haemorrhagic shock. The 
la tte r  tended to  respond in the early stages, both in the c lin ica l and 
experim ental s ituation, to  flu id  adm in istration (Burnett 1947), but 
once i t  was established flu id  adm in istration was in e ffec tua l. This 
was termed the re frac to ry  stage. In contrast, septic shock was 
largely unresponsive to  flu id  therapy (Fine 1954).
L iver fa ilu re  had been suspected as a major fa c to r in the 
development o f the re frac to ry  stage in haemorrhagic shock fo r a 
va rie ty  o f reasons. Whipple (1920) showed tha t live r damage 
produced by ch loroform  caused severe shock. Blalock (1937) 
demonstrated tha t hepatic blood flow , as measured by 
bromosulphalein clearance, was reduced in haemorrhagic shock. 
Seligman (1948) showed tha t the re frac to ry  stage in haemorrhagic 
shock could be reversed in the dog by infusing its  po rta l vein w ith  
a rte ria l blood from  a healthy donor. I f  the infusion was made in to  a 
systemic vein, there was no reversal o f the re fra c to ry  stage. 
Seligman suggested tha t the donor blood protected the shocked live r 
from  hypoxia, preventing the release o f a "vascular tox in " in to  the 
general c ircu la tion .
The existence o f a vasodepressor substance in cold saline extracts 
from  a shocked live r was shown by Shorr (1945). He believed tha t 
th is vasodepressor substance was a normal body compound which was 
destroyed by the healthy live r and tha t prolonged ischaemia inh ib ited 
this process.
In haemorrhagic shock, Burnett (1947) observed tha t the greater the 
tim e  lapse between blood loss and flu id  adm in istra tion, the less 
e ffe c tive  was the response. Fine (1951) thought th a t secondary 
invasion by endogenous bacteria m ight be the cause o f th is , and used 
a haemorrhagic shock dog model to  extend Burne tt’s findings. Fine 
treated ha lf his animals w ith  an tib io tics (aureomycin, neomycin or 
terram ycin) p rio r to  bleeding them, and found 88% surviva l in those 
tha t received antib io tics , and only 20% survival in those th a t did not 
(Fine 1951). Neomycin, which does not inh ib it C lostrid ium  w e lch ii in 
the gut, was as e ffe c tive  as aureomycin and te rram ycin , which do. 
Equally, C los trid ia l toxoid adm in istra tion, to eradicate any tissue 
C lostrid ia , fa iled to  improve survival (Fine 1952). These experiments 
enabled Fine to  ru le out C lostrid ia  as the causative organisms.
Fine thought tha t bacteria l invasion by the normal flo ra  o f the 
gastro in testina l t ra c t m ight cause the re fra c to ry  state in 
haemorrhagic shock. To test th is, he cultured blood from  dogs during 
haemorrhagic shock, but found no evidence o f invading organisms, 
even in the po rta l vein. He did, however, obtain positive cultures 
from  blood taken from  the porta l vein, im m ediate ly a fte r death or 
sacrifice , in both contro l and shocked animals, the la tte r  giving many 
more positive cultures (Fine 1954). This suggested tha t bacteria  from  
the gut obtain access to the po rta l vein and are norm ally removed by 
the live r as quickly as they invade.
Septic Shock
Shock can be classified in to  broad categories as indicated in Figure 1; 
however, a number o f underlying causes may be acting together. Its 
c lin ica l features include the compensatory mechanisms: re fle x  
tachycardia; vasoconstriction; tachypnoea; and red is tribu tion  o f blood 
flow  to  v ita l organs at the expense o f skin blood flow  and gut blood 
flow .
Patients in cardiogenic or hypovolaemic shock have the same 
underlying problem, i.e ., a reduced cardiac output, and they w ill 
exh ib it many c lin ica l features in common; tachycardia, hypotension, 
tachypnoea, cold clammy pale skin, o liguria , confusion and collapsed 
peripheral veins. In d is tribu tiona l shock the problem is a "re la tive  
hypovolaemia" brought about by an increase in the capacity o f the 
vascular tree which is in turn  due to  a reduction in tone in the 
peripheral arte rio les. Sepsis is the commonest cause o f th is  
condition.
The c lin ica l p ic ture  in septic shock (at least in the early stages) 
d iffe rs  from  tha t seen in cardiogenic or hypovolaemic shock. The 
underlying pathophysiology is much more complex than was in it ia lly  
supposed, but in essence, patients w ith  sepsis are in it ia lly  
hypercatabolic w ith  a high cardiac output. One o f the earliest 
changes is a reduction in peripheral vascular resistance accompanied 
by physiological arteriovenous shunting (both probably due to  an 
action o f endotoxin on small arterio les and precapillary sphincters). 
In the healthy state the sym pathetic nervous system, acting through 
alpha receptors, maintains a degree o f vascular tone. In septic shock
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th is is lost. Chernow (1985) has recently described a "down 
regulation" o f the alpha receptors as an im portant fa c to r in septic 
shock. However tha t may be, the reduction in peripheral vascular 
resistance leads to  a re fle x  increase in cardiac output, w ith  both 
increased chronotropy and inotropy. As a resu lt, systemic blood 
pressure may in it ia lly  be m aintained, making the early diagnosis o f 
septic shock d if f ic u lt .  A t a la te r stage, flu id  is lost from  the 
cap illa ry bed because o f an increase in perm eab ility , leading to  
hypovolaemia. In addition, m yocardial depression may occur because 
o f the release o f m yocardial depressant factors (Fisher e t al, 1973). 
This, together w ith  hypovolaemia, w ill obviously lead to  a reduction 
in cardiac output. This mixed pathophysiology fo rm erly  led to  the 
ra ther a r t if ic ia l d is tinction  between early and la te septic shock, w ith  
the term s warm or hyperdynamic being used to  describe the early 
phase and cold or hypodynamic being used to  describe the la te r phase. 
This d is tinction is a r t if ic ia l because many patients presenting w ith  a 
"hypodynamic" p ic tu re  - fo llow ing aggressive resuscitation w ith  f lu id , 
oxygen and inotropes -  w ill reve rt to  a hyperdynamic sta te .
As stated above, the early diagnosis o f septic shock can be d if f ic u lt .  
Nevertheless i t  remains im portant to  make the diagnosis early and to  
tre a t aggressively, since the m o rta lity  from  septic shock is around 
10% when treated early but rises to nearer 90% when trea tm en t is 
delayed (Hanson 1978).
Endotoxin
Fine has shown in experim ental animals tha t whether shock is brought 
about by G ram -positive bacteria , Gram-negative bacteria  or
haemorrhage, endotoxin is present in the c ircu la tion  (Fine e t al 1960, 
Fine e t a l 1970). This is true also o f patients w ith  G ram -negative 
sepsis and hepatic im pairm ent (Fine 1972).
Structure
Endotoxins from  a wide va rie ty  o f Gram negative bacteria  share a 
common s tructure . They consist o f three d is tinc t regions: a neutra l 
polysaccharide pa rt; an acidic polysaccharide core; and a lip id -r ich  
part, the so-called "lip id  A" (Westphal 1954) (Figure 2). The neutra l 
polysaccharide consists o f a heteropolysaccharide chain containing 
the repeating 0-specific antigenic un it. The acid ic
heterooligosaccharide core links the 0-antigen and lip id  A. There is 
l i t t le  s truc tu ra l varia tion in lip id  A among endotoxins from  
taxonom ically unrelated bacteria (Luderitz  1978). I t  appears to  be 
the prim ary toxophore o f endotoxin. This was demonstrated in 
experiments using rough and smooth mutants exposed to  m etabolic 
inh ib itors a t various stages during grow th. These showed th a t ne ither 
the 0 -  specific  chain nor the core polysaccharide were required fo r 
the expression o f endotoxic ity (Kontrohr 1978). Moreover the 
absence o f the nonacylated polar phosphate substituents o f lip id  A did 
not a lte r its  to x ic ity  (Rosner 1979). Rietschele et al (1982) have 
provided evidence tha t the tox ic  component is in tegrated in the 
acylated centra l disaccharide. However, l i t t le  is known about the 
s truc tu ra l features which make i t  so tox ic .
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Humoral factors in endotoxaemia
The m icroc ircu la tion  in the body is continuously being regulated to 
m aintain a constant environment fo r the cells. Endotoxin is capable 
o f disrupting th is fine balance by stim ula ting the release o f 
endogenous humoral facto rs . There is extensive, complex and poorly 
understood in te raction  between these factors (Figure 3), whose 
release can be brought about also by other antigens.
Endotoxin in te racts p rim arily  w ith  components present in the blood 
to e lic it ,  in animal experiments, the generalised Schwartzman 
reaction . This is characterised by in travascular c lo ttin g , especially 
in the glom erular capillaries, w ith  consequent renal c o rtica l necrosis 
(Husberg et al 1973). I t  is caused by the aggregation o f p la te le ts  
brought about by endotoxin, and in itia tio n  o f the c lo tting  cascade by 
production o f the Hageman fa c to r (fac to r X II) to  produce throm bin, 
which converts fibrinogen to f ib r in . This in turn  is fo llowed by the 
appearance o f f ib r in  degradation products due to the action o f 
throm bo lytics, such as alpha-2 antiplasm in (Bennet et al 1984). I t  is 
these products, not the fib r in  its e lf, tha t p rec ip ita te  disseminated 
in travascular coagulation (String et al 1974). Thrombin also causes 
the release o f histam ine (Schumer et al 1970a), which leads to  
splanchnic vasoconstriction (Vick 1964) w ith  stagnation o f blood in 
the splanchnic bed and hepatic porta l network (Weil e t al 1956) and 
peripheral vasodilatation (Schumer 1970b). These e ffec ts , coupled 
w ith  kin in production due to complement activa tion  by endotoxin, 
increase cap illa ry perm eability  which, together w ith  periphera l 
vasodilatation, causes profound hypotension (Eskridge 1980).
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The activa tion  o f complement by endotoxin produces up to  20 plasma 
proteins (Porter et al 1978) via a cascade system. These proteins are 
involved in host defence. There are two pathways o f complement 
ac tiva tion , the classical and a lte rna tive  pathways. The fo rm er is 
activa ted  by immunoglobulins, causing granulocyte in ju ry and 
increased vascular perm eab ility ; the la tte r  is activated by endotoxin 
and is involved in distinguishing "se lf" from  "non se lf" as w e ll as 
"in jured se lf" pe rm itting  bacterio lysis (Fearon et al 1980). While both 
these pathways norm ally o ffe r p ro tection to the host, in 
overwhelming sepsis, or endotoxaemia, complement ac tiva tion  leads 
to  a severe disruption o f the body's biochem istry and physiology, w ith  
the consequent development o f m u ltip le  organ fa ilu re  (Jacob et al 
1980).
Monocyte activa tion  by endotoxin causes the release o f in te rleuk in  1 
(Leucocytic pyrogen) which, in the presence o f prostaglandin E, 
produces fever (D inarello et al 1983), precip ita tes an in flam m atory  
response and stim ulates neutrophil oxidative metabolism and 
degranulation (Klemper et al 1978). Neutrophil ac tiva tion  due to  
in te rleuk in  1 is believed to be independent o f arachidonic products 
(D inarello et al 1983), unlike fever production.
Membrane damage to  monocytes, granulocytes and p la te le ts  by 
endotoxin stim ulates phospholipase A a c tiv ity , causing the release o f 
arachidonic acid from  tissue phospholipids. When metabolised, 
arachidonic acid produces cyc lic  endoperoxide derivatives and 
leukotrienes (Samuelsson et al 1979). In general these compounds are 
potent vasoconstrictors, pa rticu la rly  in the lung. The leukotrienes 
have been observed to  cause pulmonary oedema (Drazen et al 1980)
fo llow ing prote in exudation from  the m icrovascular s truc tu re . These 
products, together w ith  those from  fib rino lys is  and the endotoxin- 
stim ulated ac tiva tion  o f leucocytes w ith  consequent release o f 
oxygen radicals, a ll lead to the development o f the adult respiratory 
distress syndrome (Jacob et al 1980).
The M etabolic Response to  Septic Shock
In septic shock the hyperdynamic phase may be regarded as an 
a ttem pt to  overcome m icroc ircu la to ry  disturbances caused by 
m etabolic im pairm ent. The trans ition  to  the hypodynamic phase is 
characterised by m etabolic changes tha t are d iffe re n t from  those o f 
the hyperdynamic phase. Both phases are evident in the experim enta l 
and c lin ica l situations.
Three aspects o f in term ediary metabolism are m ainly a ffec ted  - 
carbohydrate, prote in and fa t.  While the responses in the la tte r  two 
are largely mediated by hormones, carbohydrate metabolism appears 
to  be d irec tly  a ffected  by endotoxin. (Figure 4).
Carbohydrate metabolism
In the hyperdynamic phase there is an enhancement o f glycogenolysis 
(Hamosh 1960) and lacta te  production (Smith et al 1973), w ith  an 
inh ib ition  o f gluconeogenesis (Kutner e t al 1974). These have the 
combined e ffe c t o f producing hyperlactaem ia fo llowed by 
hypoglycaemia. This suggests tha t the hyperlactaem ia is not anoxic 
in orig in . I t  is thought tha t these changes may be due to  adenylate 
cyclase activa tion  by endotoxin. G im bell e t al (1984) demonstrated
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INTERMEDIATE METABOLISM SEPTIC SHOCK
tha t the ce ll membrane has a binding site fo r endotoxin and tha t 
endotoxin w ill activa te  adenylate cyclase.
There is no d irec t evidence o f impaired respiration in the 
hyperdynamic phase. M yrvold et al (1975) found no change in hepatic 
or skeleta l muscle concentrations o f adenosine triphosphate in canine 
septic shock. However, Mela et al (1975) showed a decrease in 
hepatic concentrations o f adenosine triphosphate and a reduction in 
oxygen u tilisa tion  in rats fo llow ing endotoxaemia. Their suggestion 
tha t th is was due to  defective blood supply must remain 
controversia l: Lundsgaard et al (1972) found a large decrease in the 
levels o f adenosine triphosphate in ra t livers fo llow ing endotoxaemia, 
yet the fa ll in systemic blood pressure was re la tive ly  sm all.
In the hypodynamic phase o f septic shock and endotoxaemia, 
inadequate tissue perfusion and lack o f oxygen cause production o f 
lac ta te , predominantly in skeleta l muscle and the gastro in testina l 
tra c t.  The live r cannot convert th is lac ta te  back to glucose because 
the three irreversib le  reaction steps to  gluconeogenesis are inh ib ited : 
glucose 6 - phosphatase; fructose 1, 6 bisphosphatase; and
phosphoenolpyruvate carboxykinase (Ripple e t al 1972, and Berry e t 
al 1968, 1972). An inh ib ition  o f hepatic gluconeogenesis was 
demonstrated in endotoxic m ice by McCallum et al (1972). By 
tracing the incorporation o f isotope from  "^C -alanine in to
glucose, he found less than ha lf o f the label in blood glucose in those 
animals treated w ith  endotoxin compared to the contro ls. The 
inh ib ition  o f gluconeogenesis in septic shock has been examined by 
other workers (Urbaschek et al 1977, Schumer 1975). However, 
Kutner et al (1983), using rats w ith  septic shock due to  p e rito n itis ,
found tha t when assayed at optim al substrate concentrations and at 
pH 7.4, the a c tiv itie s  o f glucose 6 - phosphatase and fructose 1, 6 
bisphosphatase were normal and tha t phosphofructokinase a c tiv ity  
was increased.
A lte red substrate cycling has also been im plicated as a cause o f 
reduced gluconeogenesis and increased glycolysis. In hypodynamic 
septic shock the concentrations o f adenosine monophosphate and 
inorganic phosphate increase. This w ill result in a reduction in 
a c tiv ity  o f fructose 1, 6 bisphosphatase and an increase in a c t iv ity  o f 
phosphofructokinase due to  a lloste ric  in te rac tion . This la tte r  enzyme 
is also enhanced by fructose 2, 6 bisphosphate (Claus et al 1980). The 
fa c t tha t fructose 2, 6 bisphosphate is not a substrate fo r e ithe r 
aldolase or fructose 1, 6 bisphosphatase in ra t liv e r (P ilk is e t al 1981) 
and tha t i t  is decreased by the presence o f glucagon in ra t 
hepatocytes (Furuya et al 1980) suggest tha t th is m ediator may be 
involved in contro l o f fructose 6 - phosphate and fructose 1, 6 
bisphosphate substrate cycle. Indeed P ilkis et al (1981) have shown 
tha t ra t live r phosphofructokinase is inactive at a physiological 
concentration o f fructose 6 - phosphate unless other a llos te ric  
mediators, such as adenosine monophosphate and fructose 2, 6 
bisphosphatase are available. The ro le o f fructose 2, 6 bisphosphate 
in the contro l o f glycolysis and gluconeogenesis in septic shock must 
remain highly speculative, as there is no evidence to  show whether or 
not the level o f th is a llosteric  m ediator is a ffected by the presence 
o f endotoxin.
In endotoxaemia the conversion o f hexose to  pentose in the pentose 
pathway is stim ulated (F ilk in  et al 1970). Endotoxin has been shown
d ire c tly  to  a ffe c t Krebs cycle. Schumer et al (1975) demonstrated, in 
live r homogenates, a block between pyruvate and acety l CoA, 
resulting in a fa ll in c itra te . Succinate dehydrogenase has been 
shown, in rabbits during endotoxaemia, to  be inhib ited (Kun e t al 
1948). These e ffec ts , plus the acute lack o f oxygen, w ill reduce the 
output from  the electron transport chain. This is compounded by the 
uncoupling action o f endotoxin (Moss 1969). A reduction in the ATP : 
ADP ra tio  in prim ate live r has been demonstrated experim enta lly by 
Schumer et al (1975) during endotoxaemia.
A fa ll in the concentration o f adenosine triphosphate w ill lead to  the 
fa ilu re  o f the many ATPase transporter systems in the ce ll membrane 
(Mela et al 1970). M alfunction o f the sodium ATPase pump leads to  a 
loss o f in trace llu la r potassium, w ith  an in flux  o f both w ater and 
sodium in to the ce ll and m itochondria (Lundsgaard et al 1972), 
destroying the in te g rity  o f the membranes and cristae (White 1973).
Fat Metabolism
Lip id  metabolism in septic shock is d if f ic u lt  to  in te rp re t because 
lipolysis cannot be measured d ire c tly . Furtherm ore animals tend to  
show a d iffe re n t lip id  response from  man, making comparison 
between the experim ental model and the c lin ica l s ituation d if f ic u lt .
In man lip id  m obilisation during septic shock is a response to  the need 
fo r energy (Clowes et al 1976). I t  is mediated, at least in pa rt, by 
hormones, in pa rticu la r the catecholamines (Benedict et al 1978) via 
the adenylate cyclase system. Endotoxin is also capable o f ac tiva ting  
adenylate cyclase (G imbell 1984).
Spitzer et al (1973) showed tha t endotoxin induced lipolysis in 
adipocytes. However, Spitzer et al (1980) in a study o f adipocytes 
isolated during septic shock demonstrated tha t lipolysis was due to 
hormonal influence.
The concentration o f free fa t ty  acids in plasma is believed to  re fle c t 
th e ir turnover (Romanosky et al 1980), but in the la te  stages o f septic 
shock th is relationship becomes distorted (Nordenstrom et al 1983). 
A rise in plasma free fa tty  acid concentrations in the early stages o f 
both endotoxaemia and bacteraemia has been demonstrated in 
baboons (Horow itz 1972). However, in la te  septic shock free  fa tty  
acid concentrations are reduced and turnover decreased (Spitzer e t al 
1972). These e ffects  are probably enhanced by insulin (Neufie ld 1980) 
and hyperlactataem ia (M ille r et al 1964), both o f which are known to  
stim ulate rees te rifica tion . The low levels o f ketone bodies observed 
in septic shock (Wannemecher e t al 1979) can be rationalised in view 
o f the decreased levels o f free fa tty  acids as these are the precursors 
o f ketone bodies. Insulin has also been im plicated in the inh ib ition  o f 
ketogenesis during septic shock (Neufield 1980).
The function o f lipolysis is presumably to  supply the body w ith  fue l, 
in pa rticu la r the heart. However Scott et al (1973) found th a t the 
uptake and metabolism by the myocardium o f free fa t ty  acids was 
reduced during endotoxaemia. Furtherm ore, lac ta te  uptake was 
increased.
Protein Metabolism
In the early stages o f shock there is altered hepatic prote in synthesis 
(Wanacher e t al 1972). The proteins involved are called the acute 
phase reac tan ts . The response is com plicated by the fa c t tha t 
synthesis o f certa in  proteins is increased and others decreased. A net 
decrease in prote in synthesis w ithou t any s ign ifican t increase in 
prote in catabolism is a normal stress response. However, in shock 
there is an increase in protein breakdown presumably due to  the 
catabolic hormones. Such hormones have not been im plica ted in the 
acute phase reactants response (Bessey et al 1984).
The e ffe c t o f these hormones is to  make substrate available fo r 
energy production. However, as gluconeogenesis is blocked these 
substrates are o f lim ited  use. One such substrate is alanine and the 
plasma concentration o f th is amino acid has been shown to  rise in 
patients w ith  re frac to ry  shock (La Brosse 1967). Many other amino 
acids are found at increased levels in plasma during shock (Coran et 
al 1972).
The L iver in Septic Shock
Anatomy
The liv e r is the largest organ in the body, weighing approxim ate ly 1.5 
kg. I t  is located in the rig h t hypochondrium and extends across the 
epigastrium . I t  is a reddish-brown, wedge-shaped organ which is 
pliable but f irm . The m a jo rity  o f the live r is protected by the 
thoracic cage. The convex upper surface f its  under the lower
surfaces o f the domes o f the diaphragm. The poste ro -in fe rio r surface 
moulds to  the adjacent viscera, giving rise to  an irregu lar 
appearance. The live r is divided in to a large r ig h t lobe and a sm aller 
le f t  lobe by the fa lc ifo rm  ligam ent. The rig h t lobe is subdivided in to 
the quadrate lobe and caudate lobe by the gall bladder and in fe rio r 
vena cava. The porta hepatis is located on the pos te rio r-in fe rio r 
surface, and houses the rig h t and le f t  hepatic ducts, the r ig h t and le f t  
branches o f the hepatic a rte ry , the po rta l vein and several lymph 
nodes. (Figure 5).
Physiology
Blood is conveyed to  the liv e r by the porta l vein and hepatic a rte ry , 
both o f which enter at the porta hepatis. The hepatic a rte ry  
transports oxygenated a rte ria l blood arising from  the aorta, while the 
po rta l vein is formed by the jo ining o f the superior mesenteric vein, 
conveying venous blood from  a large area o f the gastro in testina l 
t ra c t,  and the splenic vein, bringing venous blood from  the stomach, 
spleen, pancreas and ga ll bladder.
The porta l vein divides in to branches called the in te rlobu la r veins, 
which surround the lobules o f the live r and supply blood to  the 
sinusoids via vascular capillaries. The sinusoids, in tu rn , meet a t the 
centre o f the lobule and drain in to the in tra lobu lar branch o f the 
hepatic vein.
S im ila rly , the hepatic a rte ry  divides in to branches which fo llow  those 
o f the po rta l vein between the lobules. U ltim a te ly  the hepatic a rte ry  
blood enters the sinusoids and mixes w ith  blood from  the po rta l vein.
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DIAGRAM OF THE HEPATIC STRUCTURE
These capillaries do not possess specific  endothelial lin ing , which 
allows them to ram ify  between the hepatocytes. A t in terva ls along 
the sinusoids are the ste lla te  cells o f K up ffe r, which form  part o f the 
re ticu loendothe lia l system.
In man, the liv e r receives 1500 m l o f blood per m inute, which is 
approxim ately a quarter o f the cardiac output. O ne -fifth  o f the 
blood supply to  the liv e r comes from  the hepatic a rte ry  and the rest 
from  the po rta l vein. Dye d ilu tion  studies show tha t the blood from  
the superior mesenteric vein enters m ainly the rig h t lobe o f the live r, 
whereas splenic blood is d istributed to the le f t  lobe. The mean 
pressure in the hepatic a rte ry  is about 100 mm Hg while tha t in the 
po rta l vein is only 5 mm Hg. I f  there is increased cap illa ry resistance 
to  the porta l flow , porta l pressure w ill rise, causing retrograde 
congestion.
The presence o f a dual blood supply to  the liv e r can present problems 
in the measurement o f hepatic blood flow . The existence o f
arteriovenous cap illa ry connections between the po rta l vein and 
hepatic a rte ry  allows shunting between the two vessels, which also 
hinders hepatic blood flow  measurements.
L ive r Function in Septic Shock
The hepatocyte membrane has been shown to  be damaged in 
endotoxaemia, as has the liv e r ’s capacity fo r detoxication (White e t 
al 1973). The K up ffe r cells are thought to  be one o f the sites o f 
uptake o f endotoxin (Jacob et al 1977). Hepatic phagocytosis is 
m ainly responsible fo r the clearance o f blood borne partic les (Spence
et al 1972). This function is a ffected  by the number and size o f the 
partic les, the presence o f opsonins, the functiona l state o f the 
K up ffe r cells and the blood flow  through the live r (Saba et al 1970).
Failure o f the K up ffe r cells would be expected to lead to endotoxin 
derived from  the gut spilling over in to the general c ircu la tion  and 
causing severe damage (Nolan 1981). H isto log ica l exam ination o f the 
K up ffe r cells in patients who had died o f septic shock revealed 
hyperplasia (Ledingham et al 1978), and K up ffe r cell im pairm ent has 
been reported in septic shock (Saba et al 1983). This im pairm ent 
appears to  be re lated to  a fa ll in plasma fib ronectin  levels (Saba et al
1978). The la tte r  is known to  augment re ticu loendothe lia l function  
by non-specific opsonisation (Saba et al 1978).
On the other hand live r function in patients w ith  septic shock, as 
measured by standard tests, does not show any relationship w ith  the 
onset o f the condition, its  severity or the patients prospects o f 
survival (Ledingham et al 1978). There seemed therefo re  a need to  
measure liv e r function in septic shock in term s o f its  blood flo w , its  
detoxify ing capability  and K up ffe r ce ll function .
L ive r Blood Flow Measurement
D ire c t e lectrom agnetic measurement o f live r blood flow  (Kolin  1936) 
necessitates opening the abdomen and is therefore  possible in 
patients only in the course o f surgery. Ind irect measurement is easy 
but does not d iscrim inate between the contributions o f the hepatic 
a rte ry  and porta l vein. The clearance method is the sim plest 
example o f th is technique, and is based on F ick ’s princ ip le . A dye
which is taken up and cleared by the liv e r is in jected in to  the blood 
stream and its  ha lf life  in plasma used as an ind icator o f live r blood 
flow . Bromosulphalein was one o f the f ir s t  dyes to  be used. 
However, i t  can be removed by tissues other than live r, pa rticu la rly  
i f  the liv e r is diseased (Bradley 1950). Bromosulphalein also 
undergoes enterohepatic rec ircu la tion  (Lorber et al 1953) and its  
plasma clearance does not always fo llow  an exponential decay 
pattern  (Caesar et a l 1961). In contrast, the tricarbocyanine dye, 
indocyanine green, is e lim inated exclusively by the liv e r, undergoes 
no enterohepatic c ircu la tion  (Wheeler et al 1958) and fo llows an 
exponential ra te o f plasma clearance (Caesar et al 1961).
Despite these differences, the two dyes give s im ila r measurements o f 
liv e r blood flow  in healthy human subjects (Caesar et al 1961). 
However, in subjects w ith  live r disease, bromosulphalein tends to  give 
a higher apparent flow  than indocyanine green.
The use o f indocyanine green fo r measuring live r blood flow  has 
largely superceded bromosulphalein. When i t  is in jected 
intravenously, 95% binds to albumin. Its disappearance from  the 
plasma fo llows f irs t  order k inetics, therefore its  h a lf- life  is constant. 
The greater part o f the dye is removed from  the blood during a single 
tran s it through the live r. Clearance is normal in acute hepatitis , but 
diminished in chronic hepatitis  and cirrhosis, and diminished s t i l l  
fu rth e r in alcoholic cirrhosis (G ilmore et al 1982).
Detoxication in the liv e r 
Im pairm ent o f the liver's capacity fo r detoxication during 
endotoxaemia or septic shock m ight contribute to the high m o rta lity  
observed in both these conditions.
D etoxication is brought about by the microsomal cytochromes o f the 
hepatocyte. Commonly i t  takes the form  o f oxidation o f a lip id - 
soluble compound to  a more w ater soluble structure  by the 
cytochrome P450-linked mono-oxygenase system. A lm ost a ll 
compounds which act as substrates fo r the cytochrome P450 system 
are lipoph ilic , probably because the enzyme system is an in tegra l part 
o f the lip id  in the membrane. The cytochrome P 450 enzyme system 
is only found in certa in  cells, such as live r and lung. No cytochrom e 
P 450 has been found in foe ta l live r, und iffe ren tia ted  tissue (Dallner 
et al 1965) or certa in types o f hepatomas (Ikeda 1965). The electron 
transport system o f the liv e r microsomes consists o f cytochrom e b5, 
cytochrome P 450 and th e ir respective reductases (Figure 6). The 
main function o f cytochrome b5 and its  reductase is to  supply 
reducing power to cytochrome P 450 to allow i t  to carry out the 
various oxidation reactions. Reducing power is abundant fo r such 
reactions o f the microsomal system, as the endoplasmic re ticu lum  o f 
the hepatocyte is surrounded by the cytoplasm, where reducing 
equivalents in the form  o f NADPH are free ly  available. The 
components o f th is e lectron transfe r system are am phipathic 
membrane proteins. (Ito et al 1968). Cytochrome P450 is la rge ly 
hydrophobic (Alvares et al 1973) whereas cytochrome b5, NADPH 
cytochrome c reductase and NAPH cytochrome c reductase a ll 
contain a large hydrophilic component. (Spatz et al 1971, Welton et 
a l 1973, Spatz e t al 1973). The m ajor hydrophilic parts, which are the 
ca ta ly tica lly  active portions, protrude from  the membrane in to  the 
cytoplasm (Takesue et a l 1976). Although cytochrome P 450 is 
extrem ely hydrophobic, i t  must also extend in to the cytoplasm to  
receive electrons from  NADPH cytochrome c reductase.
Figure 6
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During endotoxic shock, disturbances in drug metabolism and 
detoxication have been observed (Vaino 1973, M ori et al 1973 and 
Gordischeri et al 1966). The cytochrome P 430 content o f human 
live r has been shown to be decreased in live r disease to  a degree 
re la ted to  the severity o f the condition (Brodie et al 1981). Many 
workers have used the h a lf- life  in plasma o f antipyrine (Phenazone) 
as a measure o f cytochrome P 430 a c tiv ity  in the hepatic 
microsomes. Antipyrine is metabolised by the m icrosom al 
cytochrome P450 system. (Poland e t al 1970). McManus et al (1979) 
demonstrated good corre lation in rabbits between hepatic m icrosomal 
metabolism o f antipyrine in v itro  and its  h a lf- life  in vivo. Drugs 
known to in h ib it m icrosomal cytochrome P450 function o f the liv e r 
prolong the plasma ha lf l ife  o f antipyrine (Vessel e t al 1973, Welch e t 
al 1975), whereas drugs th a t induce m icrosomal cytochrome P450 
a c tiv ity  s ign ifican tly  shorten i t  (Stevenson et al 1972,).
The K up ffe r Cell
The removal o f c ircu la ting  bacteria  by the re ticu loendothe lia l system 
was f ir s t  reported by Wyssokowitsch in 1886. The fa ilu re  o f th is  
system to remove bacteria and endotoxin from  the blood has been 
im plicated in the genesis o f septic shock (Zweifach et al 1957).
The re ticu loendothe lia l system is composed o f sessile macrophages 
located in the bone m arrow, lung, spleen and live r. The liv e r is 
responsible fo r 85% o f the body’s to ta l phagocytic a c tiv ity  (Saba et al 
1970). I t  is the s te lla te  cells o f K up ffe r tha t perform  th is function . 
They constitu te 15% o f the to ta l hepatic population (Gates e t al 
1961). In animals, K up ffe r ce ll function has been demonstrated using
carbon collo id  (Biozzi et al 1965), lip id  emulsion (Di Luzio 1964), 
bacteria (S tiffe l et a l 1970) and endotoxin (Di Luzio 1964). Human 
studies have also shown K up ffe r ce ll clearance o f bacteria  and 
endotoxin in man. (Saba et al 1979). Clearance is dependent on 
factors such as live r blood flow , the concentration o f fore ign 
partic les, the functiona l state o f the K up ffe r cells and the presence 
o f opsonins (Saba et al 1970).
Phagocytosis depends on the a b ility  o f the re ticu loendothe lia l system 
to  d iffe re n tia te  between healthy indigenous tissue and diseased and 
fore ign m atte r (Di Luzio et al 1971, A llen e t al 1973). Opsonins have 
been im plicated in th is (Niehaus et al 1980, Saba 1979). Plasma 
fib ronectin  has been shown to  act as an opsonin in the uptake o f 
carbon by perfused live r (F ilkins et al 1966). In vivo its  concentration 
in plasma fa lls  a fte r intravenous in jection o f co llo id . This is 
accompanied by depression o f re ticu loendothe lia l function , which can 
be reversed by the adm in istration o f exogenous fib ronectin  (Saba et 
al 1969, Cornell et al 1973). I t  seems reasonable to suppose th a t, 
when e ither live  bacteria or endotoxin enter the blood stream , they 
bind plasma fib ronectin  to form  an opsonised complex. This complex 
would be bound to the K up ffe r ce ll membrane and ingested fo r 
in trace llu la r destruction or degradation (Saba et al 1970, Saba et al 
1975). (Figure 7).
The re ticu loendothe lia l system appears to form  a f ir s t  line o f defence 
against shock (Zweifach et al 1957, 1958, Zweifach 1960, 1964), and 
im pairm ent occurs early in shock. Im pairm ent or blockade o f the 
system diminishes resistance to shock, whereas hyperfunction 
improves i t .  In experimental animals there is a close corre la tion
Figure 7
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Sequence o f physio logical events invo lved in the clearance o f 
bacte ria  and endotoxin from the blood by the stellate cells o f K u p ffe r
between the degree o f shock and the degree o f re ticu loendothe lia l 
im pairm ent. In m ild shock, im pairm ent can be reversed to  some 
exten t. In contrast, in severe shock there is a rapid decline in 
re ticu loendothe lia l function u n til death supervenes (A ltu ra  et al 1967, 
1971, 1972). In rats adm in istra tion o f antiserum to  fib ronectin  
produces a decrease in phagocytosis in rough proportion to  the dose 
given (Saba et al 1978).
F ibronectin
F irbronectin  is a high m olecular weight alpha-2 glycoprote in present 
in plasma (Morrison e t al 1948), on ce ll surfaces (Yamada et al 1976) 
and in ce ll m atrices (Hynes et al 1978). I t  exists in two form s - 
plasma and ce llu la r fib ronectin . Plasma fib ronectin  was f irs t  isolated 
by Morrison et al in 1948. Its peptide structure  is d iffe re n t from  tha t 
o f ce llu la r fib ronectin  (Hayashi et al 1981) but the amino and carboxy 
term inals are s im ila r in both, suggesting tha t two separate genes may 
exist and tha t the differences are not due to postranslational 
m od ifica tion . While both form s o f fib ronectin  have s truc tu ra l 
d ifferences which can be detected using monoclonal antibodies 
(A ltherton  et al 1981), they are im m unologically indistinguishable 
using polyclonal antisera.
Plasma fib ronectin  is a dimer o f two s im ila r, but not iden tica l, 
polypeptide chains, each weighing 220,000 daltons, which are linked
by disulphide bridges (Mosesson et al 1975). In the aqueous
environment the prote in shows no evidence o f a lpha-helical content 
and only small amounts o f beta-pleated sheet (Mosesson et al 1975). 
I t  appears to consist o f large domains connected by randomly ordered
f lex ib le  polypeptide sequences, which would allow f le x ib il ity  to  the 
domains. These domains have been shown to have binding sites fo r 
Staphylococcus aureus (Mosher et al 1980) f ib r in  (Jilek e t al 1978)
collagen (Mosher et al 1980) heparin (Smith et al 1982) and
fib ronectin  (Hormann et al 1980). (Figure 8). Although fib ronectin  is
synthesised by many cells in the body, Tamkun et al (1983)
demonstrated tha t the liv e r is the main source o f synthesis fo r 
plasma fib ronectin .
F ibronectin measurement involves the use o f antiserum raised against 
human fib ronectin  in rabbits. The im m unotrub id im etric  technique 
has largely superceded electroimmunoassay because i t  o ffe rs  
im m ediate results, requires m inim al amounts o f plasma and can be 
perform ed at the bedside. Saba (1981) demonstrated tha t the 
im m unoturb id im etric  technique corre lates w e ll w ith  the other types 
o f assays available. Bioassays, on the other hand, o ffe r the
advantage o f measuring functiona l a c tiv ity . Such assays u tilise  liv e r 
slices (Saba et al 1969), peritoneal macrophages (Doran e t al 1980), or 
K up ffe r cells (Saba et al 1986) and measure the degree o f opsonic 
a c tiv ity . However, these assays are not suitable fo r bedside use and 
are tim e  consuming.
Opsonic Function o f  Plasma F ibronectin
Fibronectin is believed to be an opsonin which w ill s tim u la te  
re ticu loendothe lia l system function . Plasma fib ronectin  is capable o f 
improving live r and spleen clearance o f particu la te  m a tte r (Saba 
1970), as w e ll as improving macrophage phagocytic a c tiv ity  (Saba et 
al 1975). A decrease in plasma fib ronectin  levels has been shown to
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be associated w ith  reduced clearance o f particu la te  m a tte r (Kaplan 
et al 1976). However, Bevilacqua et al (1981) demonstrated tha t 
human macrophage binding o f fib ronectin-coated partic les is 
reversible in the presence o f trypsin , suggesting tha t opsonisation had 
not taken place. In contrast, Gudewicz et al (1980) using ra t 
macrophages did demonstrate opsonisation. Bevilacqua et al (1981) 
also found tha t fib ronectin  stim ulated monocyte binding o f 
fibrinogen, but not opsonisation. However, Pommier et al (1983) 
found tha t sheep cells coated w ith  immunoglobulin G were 
phagocytosed by monocytes in the presence o f fib ronectin , but i f  the 
sheep red cells were coated w ith  immunoglobulin M opsonisation and 
phagocytosis did not take place.
When the re ticu loendothe lia l system is blocked by an in jec tion  o f 
gelatin co llo id , fu rthe r in jections o f collo id are not removed by the 
re ticu loendothe lia l system (Saba 1970). This blockade results in 
reduced resistance to  endotoxin and bacteria (Saba 1970). Saba 
observed tha t fo llow ing the f ir s t  in jection  o f co llo id  plasma 
fib ronectin  levels fe ll (Saba 1970). When th is work was repeated 
using bacteria , the same results were obtained, w ith  the development 
o f neutrophil-m ediated pulmonary margination o f bacteria  (Saba et al 
1975). The reduction in plasma fib ronectin  corre lates w e ll w ith  
reticu loendothe lia l im pairm ent and this im pairm ent can be reversed 
by restoring fib ronectin  levels to normal (Saba et al 1975). Animals 
w ith  low fib ronectin  levels died, but death could be prevented i f  the 
fib ronectin  levels were restored to norm al. In human studies 
involving sepsis, Lanser et al (1982) have shown tha t a fa ll in plasma 
fib ronectin  is not merely a re fle c tion  o f the sepsis, but tha t the host 
defence mechanisms to sepsis are severely compromised. Reduced
levels o f plasma fib ronectin  have been im plicated in the development 
o f disseminated in travascular coagulation. Bang e t a l.,(1973) observed 
tha t f ib r in /fib ro n e c tin  complexes develop in the blood as 
disseminated in travascular coagulation progresses. This suggests tha t 
the depleted fib ronectin  levels observed in sepsis may be secondary 
to disseminated in travascular coagulation in some cases.
Plasma F ibronectin in Disease
Plasma fib ronectin  levels have been reported to  be altered in various 
diseases. They are increased in b ilia ry  cirrhosis, obstructive jaundice 
and the nephrotic syndrome (Stathakis et al 1981), and depressed in 
some cancer patients, pa rticu la rly  those w ith  extensive liv e r 
metastases (Mosher e t al 1978). In contrast, Stathakis e t al (1981) did 
not observe this pattern in his cancer patients. Low levels o f 
fib ronectin  are also observed fo llow ing in jury (Saba et al 1975), burns 
(Saba et al 1975), and major surgery (Blumenstock et a l 1977). Low 
levels o f fib ronectin  corre late w e ll w ith  the degree o f disseminated
in travascular coagulation (Mosher et al 1978), pa rticu la rly  in
septicaem ia. Richards et al (1983) reported tha t plasma fib ronec tin  
levels were reduced in in tra-abdom inal sepsis, and tha t three patients 
in his study who developed m u ltip le  organ fa ilu re  had the lowest 
fib ronectin  levels. Ahlgren et al (1985) observed tha t reduced plasma 
fib ronectin  levels were a consistent finding in septic patients, and 
tha t a transien t, as opposed to sustained, fa ll in plasma fib ronec tin  
s ignified a good prognosis. They also found tha t the degree o f 
hypofibronectinaem ia was more marked in G ram -positive sepsis than 
in Gram-negative sepsis.
In intensive care patients, Rubli e t al (1983) found tha t those tha t 
were septic had a s ign ifican tly  lower fib ronectin  level than those th a t 
were not. In th e ir septic patients m o rta lity  was lower in those 
patients w ith  fib ronectin  levels above 200 mg m l” ^. Po tt e t al (1981) 
also found tha t plasma fib ronectin  levels were reduced in human 
septic shock.
The fa ll in plasma fib ronectin  levels observed in many conditions may 
be re lated to  increased consumption, decreased synthesis or changes 
in turnover. While tissue damage w ill increase consumption and 
hypoxia w ill reduce synthesis, the reason fo r the fa ll in plasma 
fib ronectin  is not yet fu lly  elucidated.
F ibronectin Replacement Therapy
Several authors have reported tha t hypofibronectinaem ia is 
associated w ith  a high m o rta lity  ra te  (Mosher et al 1978, Scovill e t al 
1978, Couland et al 1982) and i t  has been suggested tha t reversal o f 
th is defic iency may improve prognosis (Saba et al 1978). Depleted 
fib ronectin  levels observed in sepsis can be augmented by the 
adm in istration o f cryoprec ip ita te  (Scovill e t al 1978, Scovill e t a l
1979). These authors found an improvement in pulmonary a rte r io ­
venous shunt and an increased peripheral blood flow  a fte r  
cryoprec ip ita te  adm in istra tion. Saba et al (1980) observed th a t in 
septic patients cryoprecip ita te  infusions reduced pyrexia and 
increased oxygen delivery to  the tissues.
The h a lf- life  o f cryoprec ip ita te  used by Scovill e t al (1978) was 
approxim ately 36 hours in his patients. However, th is  finding is
d if f ic u lt  to  in te rp re t because no a ttem pt was made to  assess the 
severity o f illness. This, and the absence o f controls, and the sm all 
number o f patients in such tr ia ls  using cryoprecip ita te  as a source o f 
fib ronectin , must therefore  make the value o f cryoprecip ita te  in the 
trea tm en t o f sepsis and septic shock speculative.
While cryoprec ip ita te  raises depleted fib ronectin  levels, i t  is also a 
source o f many other proteins, such as fibrinogen and fa c to r VIII - 
both o f which may be reduced in sepsis due to disseminated 
in travascular coagulation. I t  is therefore d if f ic u lt  to  a ttr ib u te  the 
improvements associated w ith  cryoprec ip ita te  adm in istra tion solely 
to  fib ronectin . Saba et al (1986) attem pted to  c ircum vent th is 
problem by using purified  human plasma fib ronectin . In a group o f six 
patients w ith  conditions including in jury and sepsis, infusions o f 
purified  human fib ronectin  successfully raised plasma fib ronectin  
levels. Opsonic a c tiv ity , as measured by the peritoneal macrophage 
assay, was increased. Saba also administered th is  purified  fib ronectin  
to  sheep in sepsis and observed improvements in systemic vascular 
resistance, pulmonary vascular resistance and blood pressure (Saba et 
al 1986).
C LIN IC A L STUDIES IN  SEPTIC SHOCK
Physiological Measurements
Electrocardiography was monitored via 3 standard electrodes and 
displayed on a Kone patient data m onitor 363A.
A rte ria l blood pressure was measured via an indwelling a rte ria l 
catheter connected to  a disposable pressure transducer (Gould) w ith  a 
continuous wave trace displayed on the Kone m onitor.
Tem perature: Core tem perature was measured using a re c ta l 
the rm isto r probe. Peripheral tem perature was measured using a 
therm istor probe attached to one o f the toes and the respective 
temperatures displayed d ig ita lly  on the Kone m onitor.
Pulmonary arte ry  pressure: This was measured via a pulmonary 
a rte ry  flo ta tio n  catheter located in the pulmonary a rte ry , connected 
to a disposable pressure transducer and the wave form  displayed on 
the Kone m onitor.
Pulmonary a rte ry  wedge pressure was measured by in fla tin g  the 
te rm ina l balloon on the pulmonary arte ry  f lo ta tio n  cathe ter, ensuring 
tha t a wedge trace was obtained on the Kone m onitor. The wedge 
pressure was calculated at end-expiration.
Cardiac output was measured by in jecting 10 m l o f dextrose 5% at 
0°C through the proxim al port o f the pulmonary a rte ry  f lo ta tio n  
catheter in to  the righ t a trium . The therm isto r 4 cm behind the end 
o f the pulmonary arte ry  flo ta tio n  catheter detected the resulting 
tem perature change. Using a Kone cardiac output console (538) the 
cardiac output was calculated and displayed on the Kone m onito r. 
Measurements were performed in tr ip lic a te  and the mean value 
recorded.
Urine output was measured hourly via an indwelling urinary ca the ter. 
A rte ria l and mixed venous blood gases: 2 m l samples o f blood, from  
e ither the a rte ria l line fo r a rte ria l blood gas analysis or the d ista l 
port o f the pulmonary arte ry  flo ta tion  catheter fo r a mixed venous 
sample, were drawn in to heparinised syringes containing 50 [ i \  o f 
heparin (1000 units ml"'*'). The samples were analysed using a blood 
gas machine (radiom eter ABL3).
Biochemical Measurements
Indocyanine Green Measurements
Clearance measurements
Indocyanine green was reconstitu ted in 10 m l o f solvent im m ediate ly 
p rio r to use. 3 m l o f blood was drawn from  the indwelling a rte r ia l 
ca theter or via a 21g b u tte rfly  needle and an intravenous bolus o f 
indocyanine green (0.5 mg kg""*" body weight) was adm inistered 
through the centra l venous catheter or by venepuncture. 1.5 m l blood 
samples were taken every 3 mins. fo r 21 mins. and placed in prim ed 
EDTA Eppendorf tubes. When an intravenous b u tte rfly  needle was 
used i t  was kept patent by flushing w ith  2 m l o f heparin-saline (100 
units ml"'*') a fte r each blood sample.
Assay Procedure
This was identica l to  tha t described on Page 66, w ith  the exception 
tha t 1 jjtX o f indocyanine green (5 mg mr"*") was added to  the plasma 
blank. The calculations are also iden tica l.
Endotoxin Measurement
The method used fo r the measurement o f endotoxin was the Limulus 
Amoebocyte Lysate assay u tilis ing  a chromogenic substrate (Harris et 
al 1983) using a one step incubation. In the presence o f Limulus 
Amoebocyte Lysate activated by endotoxin, p-n itroan iline  is released 
from  the colourless synthetic chromogenic substrate, the ra te  being 
proportional to  the amount o f endotoxin present.
Blood Sampling
Full aseptic technique was observed including wearing a mask, hat, 
s te rile  gloves and a ste rile  gown. 20 m l o f blood was co llected using 
a 20 m l pyrogen-free syringe and a 21g needle, a fte r the skin had 
been cleansed using 1% (w /v) iodine in alcohol. 10 m l o f blood were 
placed in a pyrogen-free tube (Falcon 2054) containing 100 units o f 
preservative-free heparin (Leo Labs). The sample was gently mixed 
w ith  the heparin and placed im m ediate ly on ice. The remaining 10 m l 
o f blood were sent fo r blood cu ltu ring . (Blood cultures were 
perform ed by the Western In firm ary 's  Bacterio logy Laboratories).
The sample remained on ice fo r 30 mins. to a llow  p a rtia l 
sedimentation o f the cells and was then centrifuged at 100 x g fo r 2 
mins. (Medifuge). The p la te le t-rich  plasma was removed using a 5 
m l syringe w ith  a qu ill needle and placed in a pyrogen-free tube 
(Falcon 2054) and frozen at -20°C .
Assay Procedure
Disposable, pyrogen-free equipment was used throughout. A ll 
p ipetting was performed using Gilson P20 and Gilson P200 autom atic
pipettes. S terile , individually-wrapped p ipette  tips (S terilin ) were 
u tilised .
A com m ercia lly available k it  (QCL 100) was used (M .A. Bioproducts) 
coupled w ith  chromogenic substrate S2423 (Kabi D iagnostica). The 
k it  contained 7 vials o f lyophilised Limulus Amoebocyte Lysate (each 
v ia l was reconstitu ted w ith  1.4 m l o f pyrogen-free water a t the tim e  
o f use), and 2 ng o f lyophilised endotoxin (Escherichia co li 0111.B4) 
which was reconstitu ted w ith  1 m l o f pyrogen-free w ater (th is 
solution was stable a t 2°C fo r  31 days). Before use it  was warmed to  
room tem perature and vigorously mixed fo r 30 secs. Twenty five  mg 
o f lyophilised chromogenic substrate S2423 were reconstitu ted w ith  
16.7 m l o f pyrogen free water and divided in to  33 aliquots o f 500 [ i ' l  
placed in s te rile  m icroeppendorf tubes (S terilin) and stored a t 2°C . 
P rior to use the chromogen-substrate solution was mixed in 1:1 w a te r 
w ith  chromogen substrate bu ffe r (0.05m T e is  bu ffe r pH 7.9).
Plasma extracts were obtained by adding 100 [JD l o f p la te le t-r ic h  
plasma to  300 />ol o f extraction  bu ffe r (50 mM Tris, 10 mM M g C ^ j 15 
mM NaCl to pH 7.4) in a ste rile  m icroeppendorf tube (S terilin ) and 
heating to  100°C fo r 1 m in. The resulting p rec ip ita te  was 
sedimented by centrifug ing at 13,000 x g fo r 2 mins. using a 
m icrocentrifuge (M icrocentaur).
F if ty  m icro litres  o f plasma extrac t were added to  a s te rile  1.5 m l 
m icroeppendorf tube containing 15 f i  1 o f Limulus Amoebocyte Lysate 
and 35 A 1 o f chromogenic substrate m ixture  pre-warmed to  37°C. 
This was done in tr ip lic a te . In addition, one o f the tubes (designated 
sample contro l) contained 50 f i \  o f 50% (w /v) ethanoic acid. The
samples were incubated a t 37°C fo r 40 mins. (20 mins. in the case o f 
high endotoxin concentration), and the reaction term inated, in the 
other two tubes w ith  50jU,l o f 30% (w /v) ethanoic acid. 125 /xl o f each 
sample was transferred to  a f la t  bottom  m ic ro titre  p late and the 
absorbance read at 410 nm using a m ic ro titre  reader (Dynatech Labs). 
The standard curve fo r the assay was perform ed at the same tim e  as 
the tes t samples. Endotoxin (Escherichia co li 0111.B4) was added to  
healthy contro l plasma to give five  concentrations, w ith  a range o f 3 
pg m l"^  to  100 pg m l” ^. The assay procedure was as described.
Measurement o f Antipyrine in Plasma
Plasma antipyrine concentrations were assayed using the method o f 
(Shargel 1979).
Procedure
Six hundred m illig ram s o f antipyrine were administered intravenously 
through the centra l venous line. Ten m illil it re s  o f blood were drawn 
from  the a rte ria l line im m ediate ly p rio r to  in jection and a t 3, 5, 8, 
12, 24, 36 and 48 mins. a fte r the in jection . Samples were placed in 
lith ium  heparin tubes and centrifuged at 2000 x g fo r 5 m inutes. 
Plasma was transferred in to  a plain tube and frozen a t -20°C .
Preparation o f standard and plasma samples
Standard samples The standard samples were prepared using a stock 
solution o f 50 mg o f antipyrine in 50 mis o f methanol. The fo llow ing
concentrations were prepared from  the stock solution: 0.4 mg m l \
-1 -1 -1 -1 n  7 m l  fl ? mn ml fl 1 mm ml onrl D (IR mm ml M i n o
hundred and f i f t y  m ic ro litres  o f deionised water, 30 f l .1 o f the 
appropriate standard and 100 [ i l  o f methanol containing 10 f ig o f 4- 
m ethyl antipyrine (to serve as the in te rna l standard) were added to  a 
15 m l glass tes t tube.
Test samples The tes t samples were prepared by adding to  each 15 
m l test tube 1 m l o f the appropriate plasma sample and 100 fJLl o f 
methanol containing 10 jxg o f 4-m ethyl antipyrine.
E xtraction  Procedure
The standard and test samples prepared using the above methods 
were brought to p H l l  w ith  0.25 m l o f 0.5 M sodium hydroxide and 7.5 
m l dichloromethane added. The tes t tubes were sealed w ith  para film  
and mixed by vortexing fo r 60 secs. They were centrifuged a t 
1000 x g fo r 5 mins. and the aqueous layer was removed using a 
Pasteur p ipe tte . The dichloromethane layer was decanted in to  a 
fresh tes t tube and evaporated using a vortex evaporator a t 40°C. 
The residue was reconstitu ted in 200/xl o f methanol.
HPLC Measurement o f Antipyrine
The reconstitu ted samples were loaded in to an in jec to r carousel 
(Rheodyne 7125). Each run consisted o f 5 standards and 24 tes t 
samples a ll in duplicate. The f ir s t  two samples and the last two 
samples were identica l and served as a qua lity contro l. The in jec to r 
was programmed to  in jec t lO j^ l o f samples every 6 minutes in to  the 
HPLC column (C 18 micro-bondopac Waters number 13) which was 
connected to  a Waters single pump solvent metering system w ith  a 
mobile phase consisting o f 50% methanol and 50% w ater. The flow
ra te  was 1.5 m l min ^ w ith  a pressure o f 2500 p.s.i. A n tipyrine  was 
detected at 250 nm spectrophotom etrica lly (Cecil CE 212 UV). The 
data was recorded on a chart recorder (Phillips 8251) set at 
1 cm m in- ^. A standard curve was constructed and the antipyrine 
concentrations derived from  th is.
Plasma Fibronectin Measurements
Plasma fib ronectin  was measured using the m odified method detailed 
on Page 6 9 .  A 1.5 m l blood sample was drawn through the indwelling 
a rte ria l line via a three way tap fo llow ing the removal o f a large 
flush sample. The sample was transferred to  a primed Eppendorf 
tube containing 2 mg o f EDTA and centrifuged at 13,000 x g fo r 2 
mins. in a m icrocentrifuge (M icrocentaur). To a reaction volume o f 
500 [A 1, containing 1:21 d ilu tion  o f the fib ronectin  antiserum and 
bu ffe r, 5 f l l  o f plasma was added. The optica l density a t 365 nm was 
read at 1 m inute and again at 11 minutes using a Pye unicam SP450 
spectrophotom eter. Two standard samples were also assayed at the 
same tim e  and plasma fib ronectin  concentration was calculated.
Scoring Systems
Scoring systems have proved extrem ely useful in classifying patients 
according to  the severity o f disease, allowing comparison between 
patients or groups o f patients. Two scoring systems were used in the 
present study -  the APACHE II (Knaus et al 1985) and the Sepsis 
Score (Elebute & Stoner 1983).
APACHE II score
This scoring system is applicable to any disease process. I t  has been 
extensively studied in the Intensive Care s ituation. The score 
consists o f three parts: acute physiology component, age points 
component, and a chronic health evaluation. These are added 
together. The score has been used to  evaluate prognosis and when 
calculated at in tervals i t  allows an assessment o f response to  
trea tm en t. In the present study, scores were calculated a t the tim e 
o f admission to allow comparisons between groups. (Table 1).
Sepsis Score
Sepsis Score is a w e ll proven method o f assessing the degree o f 
sepsis. I t  is calculated on the basis o f four c lin ica l features o f the 
septic state:
Local e ffec ts  o f tissue in fection  
Pyrexia
Secondary e ffec ts  o f sepsis 
Laboratory data
Scores fo r these features were assessed according to  Table 2. The 
sepsis score is th e ir sum.
Table 1
APACHE II Score
A Acute Physiology Score
+4 +3 +2 +1 0
Temperature <29.9 30-31.9 32-33.9 34-35.9
(°c) >41 39-40.9 38.5-38.9 36-38.4
Mean Blood Pressure <49 50-69
(mm Hg) >160 130-159 110-129 70-109
Heart Rate <39 40-54 55-69
(beats m in” '*') > 180 140-179 110-139 70-109
Respiratory Rate < 5 6-9 10-11
(breaths min"* ) >50 35-49 25-34 12-24
Oxygenation < P 0 2 55 P 0 2 55-60 P 0 2 61-70 P 0 2 70
(Pa02 mm Hg)
A rte ria l pH <7.15 7.15-7.24 7.25-7.32
>7.7 7.6-7.69 7.5-7.59 7.33-7.49
Serum Sodium < 110 111-119 120-129
(mmol I ' 1) >180 160-179 155-159 150-154 130-149
Serum Potassium <2.5 2.5-2.9 3-3.4
(mmol I " 1) >7 6-6.9 5.5-5.9 3.5-5.4
Serum Creatin ine 0.6
(mg 100 ml~^) >3.5 2-3.4 1.5-1.9 0.6-1.4
H em atocrit
oCMV 20-29.9
(%) > 6 0 50-59.9 46-49.9 30-45.9
White Blood Count < 1 1-2.9
(to ta l cu.mmxlOOO) > 4 0 20.-39.9 15-19.9 3-14.9
B Age Points
Age (Yrs) Points 
44 0
45-54 2
55-64 3
65-74 5
75 6
C Chronic Health Points
I f  the patient has a positive Chronic Disease H isto ry 
(history o f severe insuffic iency or is immuno­
compromised)
a fo r non-operative or emergency post-operative 
patients -  5 points 
b fo r e lective  post-operative patients -  2 points
Table 2
Sepsis Score
A Scoring o f local e ffec ts  o f tissue in fection
A ttr ib u te Score
Wound in fection  w ith  purulent discharge/ 
enterocutaneous fis tu la  
Slight purulent discharge 2
Heavy purulent discharge 4
P eriton itis
Localised pe riton itis 2
Generalised pe riton itis 6
Chest in fection
C lin ic ia l or rad io log ica l signs w ithou t 
productive cough 2
C lin ica l or rad io log ica l signs w ith  
purulent sputum 4
Full c lin ica l m anifestations o f pneumonia 6
Deep-seated in fection 6
B Scoring o f pyrexia
A ttr ib u te Score
Maximum daily tem perature (°C) 
36-37.4 0
37.5-38.4 1
38.5-39 2
39 3
36 3
Minimum daily tem perature 37.5
Add
1
I f  2 or more tem perature peaks above 38.4 in 1 day 1
I f  any rigors occur in a day 1
Sepsis Score Continued 
C Scoring o f secondary e ffec ts  o f sepsis
A ttr ib u te  Score
Obvious jaundice (in the absence o f established
hepatobiliary disease) 2
M etabolic acidosis
Compensated 1
Uncompensated 2
Renal fa ilu re  3
Gross disturbance o f m ental o rien ta tion /
level o f consciousness 3
Bleeding diathesis (from  disseminated in travascular
coagulation) 3
D Scoring o f Laboratory Data
A ttr ib u te  Score
Blood culture
Single positive cu lture  1
Two or more positive cultures separated by 24 hrs 3
Single positive culture and history o f invasive 
procedure 3
Single positive culture and cardiac murmur and/or 
tender enlarged spleen 3
9 -1Leucocyte count (x 10 1 )
12-30 1
30 2
2.3 3
Haemoglobin level in the absence o f obvious bleeding (g dl"'*')
7-10 1
7 2
P la te le t count (x 10^ 1"^)
100-130 1
100 2
Plasma albumin level (g 1” ^)
31-35 1
25-30 2
25 3
Plasma to ta l b ilirub in  level in the absence o f 
c lin ica lly  obvious jaundice
25 umol 1 ^ 1
CHAPTER 3
ANIMAL EXPERIMENTS
Experiments on Rats
Male Sprague-Dawley ra ts weighing 150-200 grams were supplied by 
Bantin and Kingman. Each ra t had a carotid  in tra -a rte r ia l line and a 
jugular intravenous line inserted fo llow ing surgical exposure. F o rty - 
e ight hours la te r the carotid  line was connected to  a pressure 
transducer fo r m onitoring o f a rte ria l blood pressure and endotoxin 
was infused over a period o f four hours via the jugular line . For each 
dose o f endotoxin rats were sacrificed at specified tim es and the 
livers removed fo r enzyme exam ination.
Surgical Procedure fo r the Insertion o f the C arotid  and Jugular Lines
The carotid  line was constructed from  two pieces o f polythene tubing 
(Portex); the part tha t was to  be inserted in to the a rte ry  had an 
in te rna l diam eter o f 0.35 mm and a length o f 15 mm. This was sealed 
to  the second piece which had an in te rna l d iam eter o f 0.58 mm and a 
length o f 65 mm. The jugular line was constructed in a s im ila r 
manner but using sm aller bore tubing, the insertion part having an 
in te rna l diam eter o f 0.26 mm and the second part having an in te rna l 
diam eter o f 0.58 mm. Both lines were s te rilized  in activa ted  
glutaraldehyde fo r 10 minutes and rinsed in s te rile  0.9% sodium 
chloride. One hour p rio r to  surgery the ra t was given 2 f ig  o f atropine 
sulphate. Anaesthesia was induced and maintained w ith  d ie thy l ether 
using the open drop method. The thorax, head and neck were shaved 
and swabbed w ith  1% (w /v) iodine in alcohol. The ra t was placed in 
the supine position w ith  the limbs extended and taped to  s te rile
drapes. The instrum ents to  be used in the procedure had been 
s te rilized  by autoclaving.
Using a pair o f scissors a m id-line thoracic incision was made, the 
strap muscles were sp lit and the le f t  carotid  a rte ry  was located by 
blunt dissection. The fascia was stripped away and the vagal nerve 
care fu lly  separated. The arte ry  was tied  d is ta lly  w ith  a 4/0 s ilk  
liga ture  and a loose t ie  placed 15 mm prox im ally . An aneurysm clip  
was applied just above the proxim al t ie . (The vessel was kept tense 
by placing a pair o f a rte ry  forceps over the dista l tie ). Using a pair 
o f ir is  scissors a small incision was made in the superior side o f the 
a rte ry  just above the c lip . This was d ilated w ith  a pa ir o f 
m icroforceps and the carotid line, s tiffened w ith  a s ty le t, was 
threaded in to the lumen o f the vessel. Using the m icro-forceps the 
vessel and the line were gently clamped and the aneurysm c lip  
removed. The line was slowly threaded up the vessel by de lica te ly 
releasing the grip on the forceps. The proxim al t ie  was tightened to  
secure the line and the s ty le t was removed, causing a flash back o f 
blood in to the catheter which indicated correct positioning. The line 
was flushed w ith  heparin/saline (10 units m l"^) and sealed using a 
ste rile  stainless steel pin. I t  was sutured to  the strap muscle, run 
subcutaneously round the back o f the head, brought out through the 
skin and secured w ith  a 4/0 silk suture.
The same procedure was followed fo r the insertion o f the line in to  
the rig h t external jugular vein. Once the lines had been inserted the 
incision was closed using 4/0 s ilk . The ra t was given 50 f ig  o f 
morphine sulphate intravenously and was returned to  a warm cage. 
Solid food was w ithheld but free access to  10% glucose in w a te r was 
perm itted .
Blood pressure measurement and endotoxin infusion
F orty -e igh t hours a fte r surgery the ra t was placed in a m etabolic 
cage. The carotid  and jugular lines were each connected to  tubing 
encased in a flex ib le  tigh t-co iled  spring, held in the ve rtica l position 
and attached to  a counter balance weight. This perm itted  the ra t 
free run o f the cage while preventing kinking o f the tubing. The 
a rte ria l line was connected to  a pressure transducer (Gould), which 
was calibrated at the beginning o f each experim ent. Using a chart 
recorder (Device) set at 0.025 mm sec” \  a continuous pulsatile  
a rte ria l pressure trace was recorded. The line was flushed every f ive  
hours w ith  0.1 m l o f heparin/saline (10 units m l” '*') to  prevent 
c lo ttin g . The jugular line tubing was connected to  a 1 m l syringe 
which contained e ither physiological saline or endotoxin. This was 
administered intravenously over 4 hours using a syringe d rive r 
(Graseby/165A). The ra t was allowed to  se ttle  and had free  oral 
access to  10% dextrose. For each infusion a separate animal was 
sacrificed at 5, 10, 15, 20, 30 or 50 hours by cerv ica l d islocation. The 
live r was removed im m ediate ly, flushed w ith  phosphate-buffered 
saline to  remove blood, frozen in liqu id  nitrogen and stored at -70°C .
Each experiment was carried out in duplicate and 2 rats were studied 
simultaneously. A rte ria l blood pressure changes were read o f f  the 
recorded pulsatile pressure waveforms. The assays o f cytochrom e 
P450, NADPH cytochrome c reductase, NADP cytochrome c 
reductase and cytochrome b5 were perform ed at a la te r date. Rat 
corticosterone was measured by the M.R.C. Blood Pressure U n it at 
the Western In firm ary .
Microsomal Cytochrome Enzyme Assays
Microsomal preparation
Rat live r, frozen a t -70°C , was thawed in 20 m l o f ice-cold 0.15 M 
potassium chloride, 0.025 M potassium phosphate bu ffe r pH 7.5. The 
tissue was homogenised using 10 strokes o f a Potter-E lve jhem  
homogeniser w ith  a te flon  pestle (clearance 0.1 to  0.15 mm). The 
homogenate was centrifuged at 1000 x g fo r 10 mins. at 4°C to  
sediment nuclei, and fo r a fu rthe r 15 mins. a t 24,000 x g at 4°C to  
sediment m itochondria.
The post-m itochondria l supernatant was centrifuged at 105,000 x g 
fo r 60 mins. a t 4°C in Beckman tubes (39411-127-0584) using an 
u ltracen trifuge  (MSE high speed 75). The lip id  layer was removed and 
the supernatant decanted. The m icrosomal pe lle t was washed three 
tim es in the same bu ffe r and assayed fo r the respective enzymes and 
prote in content. M icrosomal suspensions were prepared by dispersing 
the pe lle t in the same bu ffe r as used fo r homogenization to  give a 
fin a l concentration equivalent to  10 f ig  prote in ml"'*'. For each assay 
the m icrosomal suspensions were fu rthe r diluted fiv e -fo ld  w ith  the 
bu ffe r appropriate to  the assay in question.
Determ ination o f Protein
The method o f Lowry et al (1951) was used. This method re lies on 
the form ation o f a coloured complex between alkaline copper phenol 
reagent and tyrosine and tryptophan residues o f the pro te in , which
can be measured by op tica l density. 50 parts 4% (w /v) Na^HCO-^ in 
0.1 M sodium hydroxide were added to  1 part o f 1% (w /v) potassium 
disodium ta rtra te  and 1 part 0.5% (w /v) copper sulphate. 1 m l o f 
prote in solution containing no more than 150 f ig  o f protein was added 
to  2 m l o f the above reagent, mixed and le f t  to  stand fo r  10 mins. 
This was followed by the addition o f 1 M Folin C iocaltean reagent, 
and the solution was mixed rapid ly and le f t  to  stand fo r 30 mins. The 
optica l density was read at 750 nm and a standard curve was 
constructed using 0.2 -  1 m l aliquots o f crysta lline  bovine serum 
albumin (200 fjg  m l“ ^ made up to  1 m l).
Cytochrome P450 Assay
The method used was th a t described by Estabrook and W erringloer 
(1978) which relies on the princip le  tha t the carbon monoxide adduct 
o f reduced cytochrome P450 is characterised by the presence o f an 
absorbance band at around 450 nm. A 1 m l m icrosomal suspension in 
50 mM T.ris bu ffe r pH 7.4 magnesium chloride 5 mM each o f two 
cuvettes, and maintained at 30°C. Using a dual beam 
spectrophotom eter (SP2-800 Pye Unicam), a base line recording was 
made. Both cuvettes were gassed w ith  carbon monoxide fo r  2 
m inutes; 1.6 mg sodium d ith ion ite  was added to  one and both were 
gassed again w ith  carbon monoxide fo r 2 m inutes. The d iffe rence 
spectrum between the cuvettes was recorded between 450 nm and 
500 nm. The change in absorbance at 450 nm re la tive  to  490 nm was 
used to calculate the concentration o f cytochrome P450 using a 
m illim o la r extinction  coe ffic ie n t o f 91 cm m M " \
Cytochrome b5 Assay
The method used was tha t described by Estabrook and W erringloer 
(1978). I t  is based on the change in absorption when cytochrome b5 is 
reduced by NADH. A 1 m l m icrosomal suspension in 50 mM Tris 
bu ffe r pH7, 5mM magnesium chloride was pipetted in to each o f two 
cuvettes and maintained at 30°C; 5 j i l  o f 0.1 mM NADH were added 
to  one o f the cuvettes and the changes in absorption a t 409 and 426 
nm were recorded. The algebraic sum o f these changes was used to  
calculate the concentration o f cytochrome b5 using a m illim o la r 
ex tinc tion  co e ffic ie n t o f 185 cm mM"'*'.
NADPH Cytochrome c Reductase
The method used was tha t tha t described by Strobel and Dignam 
(1978). The reductase-catalysed reduction o f cytochrome c was 
fo llowed spectrophotom etrica lly, by measuring the increase in 
absorbance at 550 nm. The assay m ixture  consisted o f 300 mM o f 
potassium phosphate bu ffe r PH 7.7, 40 nM o f cytochrome c, and was 
maintained a t 30°C. The reaction was in itia ted  by addition o f 5 f i l  o f 
20 mM NADPH. The ra te  o f cytochrome c reduction was calculated 
using the m illim o la r extinction  coe ffic ie n t o f 21 cm mM"'*' a t 550 nm.
NADH Cytochrome c Reductase
The method used was tha t described by M ihari and Sato (1978). I t  
depends on the a b ility  o f the enzyme to catalyse the reduction o f 
ferricyan ide by NADH. The assay m ixture  consisted o f 0.1 M 
potassium phosphate bu ffe r pH 7.5, 0.1 mM NADH, 1 mM potassium
fe rricyan ide and 500 jiil o f m icrosomal preparation in a f in a l volume 
o f 2 m l. I t  was maintained a t 30°C. The reaction was in itia te d  by 
the addition o f 10 [ i l  o f NADH and the reduction o f ferricyan ide was 
measured by a decrease in absorbance at 420 nm. The ra te  o f 
reduction was calculated using a m illim o la r extinction  co e ffic ie n t 
increm ent o f 1.02 cm m M " \  One un it o f a c tiv ity  is defined as th a t 
causing the reduction o f 1 fJLbA o f ferricyanide per m inute under these 
conditions.
Experiments on Pigs
These were designed to  establish the e ffec ts  o f Escherichia co li 
administered intravenously on the pig's haemodynamic sta te , hepatic 
m icrosomal cytochromes, plasma fib ronectin  and indocyanine green 
clearance and extraction .
Anaesthesia
Pigs weighing 20-30 kilogrammes were premedicated w ith  azaperone 
4 mg kg""*" one hour p rio r to  surgery. During th is tim e the animal was 
transferred from  the holding location to  the surgical laboratory. The 
ear was cleansed w ith  alcohol and a 16 gauge polyethylene cannula 
was inserted in to an ear vein. Anaesthesia was induced w ith  
morphine 1 mg kg"'*’ and midazolam 0.75 mg kg""*" given intravenously 
by bolus in jection. The animal was placed supine on the operating 
table and given suxamethonium 100 mg intravenously to achieve 
muscle re laxation. Endotracheal in tubation was perform ed using a 
s tra igh t bladed laryngoscope and a 6.0 mm cuffed endotracheal tube. 
Anaesthesia was maintained using 70% nitrous oxide in oxygen and 
0.5% halothane, supplemented w ith  an infusion o f morphine 1 mg kg"'*' 
h r” '*' and vecuronium 1 mg kg"'*' h r " \  the la tte r  m aintaining good 
muscle re laxation w ithout adverse e ffec ts  on the cardiovascular 
system. A Palmer pump was used to  adm inister in te rm itte n t positive 
pressure ventila tion  w ith  a t id a l volume o f 200-300 mis x 12 breaths 
per m inute. Depth o f anaesthesia was judged by pupil size, heart ra te  
and blood pressure. When adequate anaesthesia had been established, 
a cannula was inserted in to the fem oral a rte ry  to a llow  d ire c t 
measurement o f a rte ria l blood pressure. A pulmonary a rte ry
f lo ta tio n  catheter was inserted via  the external jugular vein to  allow 
measurement o f pulmonary arte ry  pressure, pulmonary a rte ry  wedge 
pressure, cardiac output and mixed venous blood gases, and a 
laparotomy was perform ed to  perm it live r biopsy fo r m icrosomal 
cytochrome determ inations.
Surgical procedure
Full aseptic technique was used, including a fu ll surgical skin 
preparation using 1% (w /v) iodine in alcohol, s te rile  instrum ents and 
disposable paper drapes. During the surgical procedure the animal 
received 20 m l kg” '*' hr"'*' o f 0.9% sodium chloride via the ear vein 
cannula.
Cannulation o f fem oral a rte ry
A skin crease groin incision was made using diatherm y (RadioTom 
612). The adductor magnus and the adductor longus muscles were 
separated to  expose the fem oral a rte ry  in its  sheath. The sheath was 
stripped, using the open-close blunt scissor technique, and the a rte ry  
ligated d ista lly  w ith  a 4/0 silk t ie . An incision was made in to  the 
lumen of the arte ry  and a 6 French polyethylene catheter inserted 
and advanced. The catheter was secured in position w ith  a 4/0 t ie  
and connected to a ste rile  disposable pressure transducer (Gould), fo r 
m onitoring o f in tra -a rte r ia l pressure. The wound was covered w ith  
s te rile  swabs.
Insertion o f pulmonary arte ry  f lo ta tio n  catheter
A short transverse cervica l incision over the carotid  and jugu lar 
vessels was made using diatherm y. The incision was deepened
through the platysma and the in te rna l jugular vein exposed by blunt 
dissection, anterio r to  the sternomastoid muscle. The vein was 
ligated proxim ally using a 4/0 silk  t ie  and a loop t ie  was placed 
d is ta lly . A small incision was made in to the lumen o f the vein. The 
pulmonary a rte ry  f lo ta tio n  catheter (7 French Swan Ganz) was
primed w ith  heparin saline (4 units m l” '*') and connected to  a pressure 
transducer linked to  an oscilloscope fo r display o f pressure wave 
form s. The in te g rity  o f the balloon was checked and the catheter 
was inserted in to the vessel under continuous pressure m onitoring, 
gently advanced in to the rig h t a trium , and the balloon in fla te d . It  
was fu rthe r advanced in to the rig h t ven tric le  and then in to  the
pulmonary a rte ry , u n til a pulmonary a rte ry  wedge phase was
obtained. The balloon was deflated and the catheter pulled back
s ligh tly  and fin a lly  positioned. A 6 French polyethylene catheter was 
inserted in to the rig h t a trium  fo r centra l venous m onitoring. Both 
lines were secured w ith  4/0 silk ties and the wound covered w ith  
s te rile  swabs.
L ive r Biopsy
A laparotomy was perform ed using an upper mid line incision. The 
live r was exposed and a biopsy (100 grams) taken from  the d ista l end 
o f the rig h t lobe. Haemostasis was achieved by inserting v e rtica l 
m attress sutures (cat gut on a 3 mm round bodied needle) behind the 
biopsy line and tightening a fte r the biopsy was removed. The biopsy 
its e lf was im m ediate ly flushed w ith  phosphate bu ffe r saline and 
frozen in liqu id nitrogen. The laparotomy wound was closed in a 
continuous single layer w ith  2/0 eth ilon.
Insertion o f posterior vena cava catheter
The fem ora l vein was exposed through the same incision as the 
fem ora l a rte ry . I t  was ligated d is ta lly  w ith  a 4/0 s ilk  t ie , and a small 
incision made through its  w a ll. A 6 French polyethylene catheter was 
threaded up the vein in to  the in fe rio r vena cava and positioned at the 
junction o f the hepatic veins and vena cava. The position was 
confirm ed, and corrected i f  need be, at laparotom y, and the catheter 
secured w ith  a 4/0 silk  t ie .
Vena cava choke
A t laparotomy the vena cava was exposed just above the r ig h t kidney 
by re trac ting  the small bowel to  the le f t .  The vena cava was 
dissected w ith  great care and a long 7 French catheter passed round 
i t  just below its  junction w ith  the hepatic veins. Both ends o f th is  
catheter were threaded through a long piece o f p lastic  tubing and 
brought out through the laparotomy incision. Occlusion o f the vena 
cava was achieved by sliding the outer tubing down the ca the ter, 
holding the la tte r  f irm ly .
Experimental procedure
Follow ing the surgical procedure, which lasted 30-45 mins., a sm all 
warming blanket was placed over the abdomen and the body covered 
w ith  paper drapes. The animal was le f t  fo r an hour to stab ilize  and 
at the end o f th is period a fu ll haemodynamic assessment was made, 
including the pulse, blood pressure, electrocardiogram , pulmonary 
arte ry  pressure, pulmonary arte ry  wedge pressure, cardiac output, 
a rte ria l blood gases and mixed venous blood gases. This assessment
was repeated hourly throughout the experiment. Blood lac ta te  and 
plasma fib ronectin  were also measured at the s ta rt o f the experim ent 
and at two hourly in tervals the rea fte r. Indocyanine green clearance 
and indocyanine green extraction  ratios were measured on selected 
animals at the beginning and end o f the experim ent. A second live r 
biopsy was also taken at the end o f the experiment.
Selection o f muscle re laxant
As th is experiment was designed to  observe the e ffe c ts  o f 
Escherichia co li on the live r and cardiovascular system, i t  was 
im portan t tha t the drugs administered should not adversely a ffe c t 
them . I t  was found tha t pancuronium, atracurium , suxamethonium 
and tubocurarine a ll led to  cardiovascular in s tab ility  (Page 133 ). 
However, vecuronium did not cause cardiovascular in s ta b ility . I t  was 
the drug accordingly chosen as the muscle re laxant.
Experim ental design
Follow ing the one-hour stabilising period, the animals were divided 
in to  three groups, a ll o f which were maintained under anaesthesia fo r 
10 hours or u n til death. Throughout they received a continuous 
infusion o f 0.9% sodium chloride at a ra te  o f 5 m l kg” "*" h r” '*’:-
A  con tro l group which received no Escherichia co li infusion ;
8 -1E. co li group which received an infusion o f 2 x 10 cells kg” 
Escherichia coli over a two hour period im m ediate ly fo llow ing 
s tabilisa tion;
E. co li co llo id  group which received a s im ila r Escherichia co li infusion 
to the above but were given collo id flu id  (Haemaccel) to  m ainta in a 
normal pulmonary a rte ry  wedge pressure.
In a ll three groups, the tid a l volume and inspired oxygen 
concentration were altered as necessary to  m aintain normal PCC^ 
and P0 2 *
Bacterio log ica l procedures
Long te rm  storage o f cu ltures. A master cu ltu re  o f Escherichia co li 
ATC number 33985 was stored at -20° as a 50% (w /v) g lycero l 
suspension. Agar cultures were grown once a month from  th is and 
stored a t 4°C . The la tte r  were then used to prepare fresh cultures as 
needed.
Bacteria l g row th . Esherichia co li were grown in media containing 16 
grams bacto-trypone, 10 grams yeast ex tra c t and 5 grams sodium 
chloride at pH 7.4. The cu lture was prepared by inoculating 100 m l 
o f s te rile  medium w ith  a single colony from  the stationary phase agar 
cultures described above, and then incubating the medium at 37°C 
w ith  vigorous aeration in an o rb ita l incubator (Gallenkamp) a t 175 
r.p .m .
C e ll harvesting. The cells were harvested in the logarithm ic phase by 
centrifug ing 20 m l o f media in a s te rile  tube a t 3000 x g fo r 10 mins 
(Beckman TJ6) at 4°C . The pe lle t was washed once w ith  0.9% sodium 
chloride.
P urifica tion  o f Porcine Plasma Fibronectin
The method used to  isolate the porcine plasma fib ronectin  was tha t 
o f Morgenthaler et al (1984) which involves gentle e lution conditions.
Method
Five grams o f C N Br-activa ted sepharose 4B (Sigma) was washed w ith  
w ater, resuspended in 30 m l Im M  HC1 fo r 10 minutes, and washed in 
a sintered funnel using 5 x 30 m l Im M  HC1 fo llowed by 30 m l o f 
carbonate bu ffe r (0.1 M Na HCO^ sodium chloride 0.5 M to  pH9). I t  
was then added to 100 m l o f carbonate bu ffe r containing 100 mg 
gelatin  (Sigma type 1). The resulting slurry was mixed a t 4°C fo r 4 
hours. The unreacted groups were blocked w ith  ethanolamine (0.1 M). 
The resulting gelatin sepharose 4B m atrix  was poured in to  a column 
0.9 x 15 cm (Pharmacia), and the m a trix  washed w ith  50 m l o f 
potassium phosphate bu ffe r saline and sodium c itra te  (10 mM o f 
potassium phosphate bu ffe r 135 mM sodium chloride 0.01 M o f sodium 
c itra te  brought to pH 7.2). Using a syringe d rive r (Graseby 165A) set 
at 1 m l min"'*' the washings were collected in a LKB fra c tio n  
co llec to r in 5 m l aliquots. 50 m l o f porcine plasma at 4°C was added 
to  the column using the syringe drivers set at 2 m l per m in. and 5 m l 
fractions co llected. E lution was carried out using the phosphate 
bu ffe r saline and sodium c itra te . However, the pH was changed from  
7.2 to  5.5. Both the bu ffe r and the column were maintained a t 30°C 
and 5 m l fractions were again co llected. The op tica l density a t 280 
nm fo r each 5 m l frac tio n  was determ ined spectrophotom etrica lly  
(Pye unicam SP800 UV). The fractions containing fib ronectin  were
pooled, and the op tica l density o f th is pooled frac tion  measured at 
280 nm to  determ ine the prote in concentration. Protein 
concentration was more accurate ly determined using the Lowry 
technique (Page 51 )• The pooled prote in frac tions ’ homogeneity was 
assessed by electrophoresis using a 5% polyacrylam ide slab gel 
containing 1% sodium d ilau ry l sulphate and 2-mercaptoethanol. The 
gel was stained w ith  Coomassie blue fo r 2 hours and destained w ith  
acetic  acid.
Development o f Porcine F ibronectin Im m unoturb id im etric Assay 
A varie ty  o f d iffe re n t antiserum concentrations, plasma 
concentrations, and reaction tim es were examined in an e ffo r t  to 
optim ise assay conditions. Human fib ronectin  antiserum (Boehringer) 
a t d ilutions o f bu ffe r o f 1:20, 1:15, 1:10, 1:7.5 and 1:5 were reacted 
w ith  each o f the fo llow ing porcine fib ronectin  standards: 50 /tg  m l” '*’, 
100/tig m l " \  200/tg m l " \  300 f ig  m l” \  400 f ig  m l” '*' and 500/tg m l” '*'. 
Each standard was tested at a volume o f 5 f i l ,  10 f i l ,  25 f i l ,  50 f i l  and 
75 f i l .  For each assay the op tica l density was read at 1 m in., 5 m ins., 
10 mins., 20 mins., 30 mins., 40 mins., 50 mins. and 60 mins. A ll 
assays were carried out in tr ip lic a te . The change in op tica l density 
between 1 m inute and each other tim e was calculated and the results 
expressed as change in op tica l density at 365 nm.
Physiological Measurements
A rte rja l Blood Pressure Measurement
A rte ria l blood pressure was measured via an indwelling catheter in 
the fem ora l a rte ry  connected to  a pressure transducer. This was kept 
patent by a continuous slow flush o f heparin saline (4 units ml"’'*'), 
from  a pressure bag. The pressure was displayed on an oscilloscope 
(Diascope 2) and also d ig ita lly  on a Mingograph (82). The la tte r  
component was capable o f producing a permanent copy o f the 
pressure wave fo rm . The m onitoring system was balanced and 
calibrated every hour.
Pulmonary A rte ry  Pressure Measurement
Pulmonary a rte ry  pressure was measured via  the pulmonary a rte ry  
flo ta tio n  catheter located in the pulmonary a rte ry  and connected to  a 
disposable s te rile  pressure transducer. S im ilar techniques to  those o f 
the a rte ria l line were employed fo r patency o f the ca the ter, 
measurement o f pressure and recording o f the in fo rm ation .
Pulmonary A rte ry  Wedge Pressure Measurements 
Pulmonary a rte ry  wedge pressure was measured by in fla ting  the 
balloon at the end o f the pulmonary arte ry  flo ta tio n  catheter u n til 
the pulmonary a rte ry  pressure wave form  changed to  a wedge trace . 
This was held over two respiratory cycles and a permanent copy o f 
the trace  made. Pulmonary arte ry  wedge pressure was calcula ted at 
the end o f the respiratory expira tory phase.
Cardiac Output Measurements
Cardiac output was measured using the therm al ind ica tor d ilu tion 
method. A chilled solution is in jected in to the blood and the resulting 
drop in tem perature is recorded at a downstream site . The cardiac 
output is calculated using the S tew art-Ham ilton equation m odified to  
take in to account a change in tem perature, ra ther than a change in 
pa rtic le  concentration.
The tem perature o f the dextrose 5% in jected was 0°C . This 
tem perature was selected as i t  reduces the instrum ent and 
physiological noise. The tem perature o f the blood was measured 
using the therm istor at the end o f the pulmonary a rte ry  f lo ta tio n  
catheter. Ten m ic ro litres  dextrose was in jected in to the r ig h t a tr ia l 
line. An Edwards cardiac output computer (9520A), connected to the 
therm istor o f the pulmonary a rte ry  f lo ta tio n  catheter, gave a d ig ita l 
reading o f the calculated cardiac output. The procedure was 
repeated tw ice  and the average cardiac output taken. The 
electrocardiogram  was observed throughout the procedure fo r the 
presence o f ectopic beats, which can s ign ifican tly  a lte r cardiac 
output measurement.
Electrocardiography
The electrocardiogram  was measured continuously using 3 electrodes 
connected to an oscilloscope (Diascope 2).
Heart Rate Measurement
Heart ra te  was calculated from  both the electrocardiogram  and the 
a rte ria l blood pressure traces and a permanent copy stored on the 
Mingograph.
Temperature Measurement
Core blood tem perature was measured via the pulmonary a rte ry  
flo ta tio n  catheter therm istor and the tem perature displayed on the 
Edwards cardiac output computer.
A rte ria l Blood Gas and Mixed Venous Blood Gas Measurements
A rte ria l blood gases and mixed venous blood gases were measured 
using a blood gas analyser (Radiometer IL). Blood was drawn in to  a 2 
m l syringe, primed w ith  50 units o f heparin in the dead space, from  
the fem oral a rte ry  catheter via a three-way tap a fte r a flush sample 
had been drawn. The same method was used to  obtain a mixed venous 
blood sample from  the d ista l port o f the pulmonary a rte ry  f lo ta tio n  
catheter. The blood gas analyser was ca librated at the s ta rt o f every 
experiment w ith  a high gas ca lib ra tion  (10% CC^) and a low gas 
ca lib ra tion  (5% 0 0 2 )- The pH electrode was calibrated p rio r to  every 
measurement.
Haemoglobin Measurement
Haemoglobin was measured using the co-oxim eter (IL 182) using blood 
obtained fo r a rte ria l blood gas measurement.
Biochemical Estimations
Indocyanine Green
Clearance measurements. Indocyanine green was reconstitu ted in 20 
m l o f solvent im m ediate ly before use. About 5 m l o f blood were 
drawn through the a rte ria l line via a three-way stop valve and 1.5 m l 
aliquots dispensed in to each o f three Eppendorf tubes primed w ith  2 
mg EDTA. An intravenous bolus o f indocyanine green clearance 0.5 
mg kg"'*' body weight was in jected via the dista l port o f the 
pulmonary a rte ry  flo ta tio n  catheter. Blood samples (1.5 m l) were 
drawn every three minutes fo r 21 minutes a fte r the in jection  and 
transferred to  Eppendorf tubes.
Measurement o f indocyanine green extracted from  blood in a single 
passage through the liv e r . Blood flow  in the in fe rio r vena cava was 
obstructed just below the live r by applying the choke described. In 
th is way the in fe rio r vena cava above the choke received only hepatic 
venous blood. A fte r  an in te rva l o f 60 seconds, base line blood 
samples (6 m l) were drawn from  both the a rte ria l and the vena cava 
catheters. The choke was released im m ediate ly a fte r the blood 
sample had been drawn. A single bolus o f indocyanine green 0.5 mg 
kg” '*' per body weight was adm inistered, as in the clearance studies, 
and a continuous infusion o f indocyanine green at a dose o f 25 mg 
over 30 minutes was set up to  produce a steady sta te . A t 5 m inute 
in terva ls the choke was reapplied and fu rthe r a rte ria l and caval blood 
samples w ithdrawn. Determ ination o f indocyanine green in these 
samples perm itted  calculation o f the percentage extracted  in 
passage.
Indocyanine green estim ation . The Eppendorf tubes were centrifuged
in a m icro-centrifuge a t 13,000 x g fo r 2 m inutes. Indocyanine green
concentrations were estimated spectrophotom etrica lly at 803 nm
(Pye unicam  SP6-450). A ll samples were read against the plasma
blank, as were two standards prepared by adding respective ly 2 f i l  and
1 fJLl o f dye (2.5 mg m l- '*') to  1 m l o f plasma blank. The calculated
plasma indocyanine green concentrations were p lo tted against tim e
on sem i-logarithm ic paper, a s tra igh t line f it te d  by eye, and
extrapolated to  zero. From this p lo t the in it ia l concentration (CQ)
and the h a lf- life  ( tA) could be measured.
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Calculation o f clearance. The in it ia l concentration o f the 
indocyanine green (CQ) and the in jected dose can be used to  ca lcu la te  
the volume (V) o f plasma throughout which the indocyanine green was 
d istribu ted.
V = _D_
Co
The observed h a lf- life  ( tA) is re la ted to  the volume o f plasma cleared
2
(Cl) per m inute thus:-
t i  = 0.693 x V 
2
Cl
Hence Cl = 0.693 x V
The volume o f plasma cleared per m inute can be converted to  the 
corresponding volume o f blood by using the haem atocrit.
E xtraction  o f indocyanine green
The mean a rte ria l-hepa tic  venous extrac tion  ra tio  (E) was calculated 
from  the 3-4 steady state measurements o f a rte ria l (a) and hepatic 
venous (hv) dye concentrations according to  the form ula:
E = a -  hv 
a
Porcine Plasma Fibronectin Assay
Porcine plasma fib ronectin  was measured using the k ine tic  
im m unoturb id im etric  technique based on the measurement o f an 
antigen - antibody reaction. This assay was developed using 
com m ercia lly available sheep antiserum to  human fib rone c tin . 
(Boehringer). (Page 62 ). This was cross-reacted w ith  standard 
porcine fib ronectin  purified  by a ff in ity  chromatography (Page 61 ).
Blood C o llection
Blood (1.5 m l) was drawn from  an a rte ria l line via a three-way stop 
valve, fo llow ing a large flush sample, and placed in an Eppendorf tube 
(1.5 m l) primed w ith  2 mg EDTA and 60 units o f aprotin in . The 
samples were centrifuged at 13,000 x g fo r 2 minutes in a m ic ro - 
centrifuge and the plasma removed, to  be assayed or stored a t -20°C  
awaiting assay.
Assay Procedure
In the im m unoturb id im etric  assay the antiserum was d iluted in a ra tio  
o f 1:10 in a solution containing 66 mM o f phosphate bu ffe r (Na2HPO^ 
and K H ^ PO^) pH 7.4 containing 3% polyethylene glycol 6000 and 1% 
B rij 33.
Five hundred m icro litres  o f the antibody bu ffe r m ixture  was p ipetted 
in to  a disposable sem i-m icro cuvette maintained at 25°C, and 30 m l 
o f plasma or standard added. W ith each batch o f assays a set o f 
fib ronectin  standards ranging from  50 mg I- "*" to  500 mg 1” ^ were 
included as controls. Follow ing the addition o f the plasma or 
standard the op tica l density (O.D.) a t 365 nm was read a t 1 m in. and 
at 30 mins. using a spectrophotom eter (Pye unicam SP6-450). The 
observed d iffe rence (Delta O.D. = O.D. 30 min -  O.D. 1 m in) between 
the two optica l densities was used to determ ine porcine plasma 
fib ronectin  level from  a standard ca lib ra tion curve. Each assay was 
carried out in duplicate.
Porcine Plasma Lacta te  Estim ation
Blood Collection
One and a ha lf m icro litres  o f blood was drawn through the a rte r ia l 
catheter via a three-way stop valve, and placed im m ediate ly in to  an 
Eppendorf tube primed w ith  3 mg o f fluoride  oxalate. The sample 
was spun in a m icrocentrifuge at 13,000 x g fo r 2 mins. and the 
plasma transferred to  a plain tube and assayed.
Assay Procedure
Two m ic ro litres  o f NAD/carbonate bu ffe r, containing 63 mM o f 
L -g lu tam ate , and 4.6 mM NAD to pHIO, was mixed w ith  40 jUl o f 
plasma. This was sp lit in to  two aliquots o f 1.02 m l in sem i-m icro
cuvettes. Twenty m ic ro litres  o f lac ta te  dehydrogenase (1632 units
-1 -1 m l ) and alanine transaminase (102 units ml~ ) were added to  one
m icro-cuvette  (sample blank) and 20 ul o f 3.2 M ammonium sulphate
to  the other. The optica l density (O.D.) at 363 nm was measured,
spectrophotom etrica lly (Pye unicam SP6-450) im m ediate ly a fte r
m ixing and again at 13 mins. The reaction was carried out a t room
tem perature. The change in op tica l density (Delta O.D.) between the
sample blank and the tes t was calculated, and the concentration o f
lac ta te  was calculated using the re la tionship:-
Delta  O.D. x 15.3 = lacta te  concentration in mM.
The test was carried out in duplicate.
CHAPTER 4
THE OBSERVATIONS ON PATIENTS IN  SEPTIC SHOCK
M odifica tion  o f the K ine tic  Im m unoturb id im etric 
Assay fo r Human Plasma Fibronectin
The prim ary objective o f th is work was to  establish the value, i f  any, 
o f the measurement o f plasma fib ronectin  levels in the diagnosis o f 
septic shock, and the usefulness o f cryoprec ip ita te  adm in istra tion in 
elevating these and improving the patient's chance o f surv iva l. 
Before s ta rting , i t  was necessary to  find  the best possible assay fo r 
plasma fib ronectin . A com m erical k it  was available from  Boehringer, 
but its  range fa r exceeded the physiological reference range and it  
was insensitive and inaccurate a t the low levels which are o f 
pa rticu la r c lin ica l in te rest. There were no published data on its  
precision, accuracy and sensitiv ity  and the m anufacturers themselves 
could find  no unpublished data in th e ir file s . Moreover, the cost per 
assay was approxim ately £2.00. I t  seemed im portant to  try  to  
improve the assay and i f  possible to  make i t  less expensive. I t  proved 
possible to  do this by reducing the reaction volume and increasing the 
antiserum d ilu tion . (Technical details o f the procedure w ill be found 
on Page43).
Reduction in reaction volume
Using the manufacturer's recommended antiserum d ilu tion  (i.e . 1 : 
11) the reaction volume could be reduced f ir s t  to  300 [ l i  and then to  
250 pi 1 simply by inserting a sm all p la tfo rm  under the sem i-m icro
cuvette holder. Each standard was assayed five  tim es, the optica l 
density being read a t 365 nm, spectrophotom etrica lly (pye unicam 
SP8-200), at 1 m inute and 11 minutes. Table 3 shows the mean 
op tica l density, standard error and coe ffic ie n t o f varia tion obtained 
fo r the five  assays carried out fo r each fib ronectin  standard using 
1000, 500 and 250 f i l  reaction volumes. Although the accuracy and 
precision obtained using the two sm aller volumes were both 
comparable w ith  the 1000 f i l  volume o f the orig ina l method, the 250 
jUi volume could not be used w ith  the manual Pye SP450 
spectrophotom eter used in the Intensive Care U n it fo r bedside 
estim ations. The 500 pt 1 reaction volume was there fo re  used 
rou tine ly .
Increase in Antiserum d ilu tion
Using a reaction volume o f 500/xl, the m anufacturer’s recommended 
antiserum d ilu tion  (1 : 11) was compared w ith  two fu rthe r d ilu tions (1 
: 21 and 1 : 31). A cryoprecip ita te  sample and a plasma sample were 
assayed in tr ip lic a te  by a nephelometric technique (carried out by the 
West o f Scotland Blood Transfusion Service) and fib ronectin  values o f 
1050 mg 1"^ and 410 mg 1“ ^ respectively were obtained. Serial 
d ilu tions o f these two standards were then prepared using bu ffe r, and 
each d ilu tion  assayed five  tim es w ith  each o f the antiserum d ilu tions. 
The values obtained, w ith  th e ir coe ffic ien ts  o f va ria tion , are shown in 
Tables 4 (cryoprecip ita te) and 5 (plasma) and the coe ffic ien ts  o f 
varia tion  fo r each d ilu tion  are p lo tted in Figures 9 (cryoprecip ita te ) 
and 10 (plasma). I f  a coe ffic ie n t o f varia tion below 7% is deemed 
acceptable, the useful ranges fo r each antiserum d ilu tion  are as 
fo llow s:-
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1 : 11 275-850 mg I " 1
1 :  21 110-530 mg f 1
1 : 31 90-150 mg I ' 1
From the above i t  can be seen tha t the 1 : 11 d ilu tion  adequately
covers the reported normal ranges fo r plasma fib ronectin , but not the 
low levels o f fib ronectin , such as have been reported in patients
suffering from  sepsis. The 1 : 31 d ilu tion  perform s best in the sub-
physiological range o f fib ronectin  levels, but is not s u ffic ie n tly  
accurate over the range o f normal fib ronectin  levels. O verall the 1 : 
21 d ilu tion  seemed an acceptable compromise.
The reduction in reaction volume to  300 ul together w ith  the increase 
in antiserum d ilu tion to  1 : 21 increased the number o f assays which 
could be performed from  one k it  fou r-fo ld . Figure 11 shows a 
comparison between the standard assay (1 : 11 d ilu tion  o f antiserum 
and 1000 [ i \  reaction volume) and the modified assay (1 : 21 d ilu tion  
o f antiserum and 300 [ i l  reaction volume), when used to  assay in 
tr ip lic a te  170 separate plasma samples fo r fib ronectin  leve l. A  good 
corre la tion was observed across the range w ith  a regression 
co e ffic ie n t value o f 0.993, although in the sub-physiological range the 
re la tive  scatte r was greater, in keeping w ith  the coe ffic ien ts  o f 
varia tion w ith in  th is range shown above.
External factors and th e ir influence on the fib ronectin  assay 
The e ffe c t o f lip id
As this assay is a tu rb id im e tric  technique i t  is im portant to  take 
account o f the possible errors due to  plasma lip id . A healthy male
subject was fasted overnight and a blood sample obtained by 
venepuncture. He then consumed a meal high in fa t and provided 
intravenous blood samples every 30 minutes fo r 8 hours. Figure 12 
shows the results obtained when these samples were assayed fo r 
fib ronectin . I t  would appear tha t the presence o f lip id  does resu lt in 
an increase in the apparent fib ronectin  level.
A second experiment was carried out on patients receiving In tra lip id  
(Kabiv itrum ) as part o f a to ta l parenteral n u trition  regimen. Blood 
was w ithdrawn through a rte ria l cannulae just before they received 
300 mis o f 10% In tra lip id , administered over 8 hours or 16 hours. 
Blood samples were taken hourly fo r the next 24 hours and assayed 
fo r fib ronectin . Figure 13 shows the results. In patients receiving 
In tra lip id  over 8 hours, the plasma was lipaem ic to  the naked eye and 
the assay was a ffec ted . In patients receiving In tra lip id  over 16 hours, 
the plasma was not obviously lipaem ic and the assay was not 
a ffected .
E ffe c t o f heparin
I t  was reported by Saba et al (1978) tha t heparin in te rfe res w ith  the 
fib ronectin  assay, producing erroneously low results. As many o f the 
blood samples from  patients would be obtained through an indwelling 
a rte ria l line which would be continuously flushed w ith  heparinised 
saline (1 un it m l"^  a t 3 m l h r“ ^), i t  was im portant to  find  out i f  
obtaining blood in th is fashion introduced an error in to  the estim ation 
o f plasma fib ronectin . Accordingly comparisons were made between 
simultaneous venous and a rte ria l samples taken from  patients, the 
venous sample by clean venepuncture and the a rte ria l sample from  an
a rte ria l line fo llow ing the removal o f a 2 m l flush sample. Table 6 
shows the results; i t  can be seen tha t w ith  an adequate flush sample 
there was no d iffe rence between a rte ria l and venous fib ronectin  
levels.
Construction o f Reference Ranges fo r Plasma Fibronectin
A reference range was established using samples from  144 young 
healthy contro l subjects a ll o f whom were free from  illness and 
taking no m edication. There are few data in the lite ra tu re  on 
fib ronectin  levels in an elderly population and, since many patients 
adm itted w ith  septic shock are e lderly, i t  was essential to  establish 
also an acceptable reference range fo r them . Samples were obtained 
from  103 elderly healthy patients who had been hospitalised fo r 
social, as opposed to m edical, reasons and had no evidence o f illness 
or malignancy and had not received any recent blood transfusion. 
Figure 14 shows the results from  both groups. The mean level in the 
elderly population was s ign ifican tly  greater than in the young 
population (368 vs 306 mgs 1~^). In te resting ly there were also 
s ign ifican t sex d ifferences in fib ronectin  levels, which reversed w ith  
age. These trends are consistent w ith  the much less extensive data 
published by Strathakis et al (1981), though these included too few 
patients over the age o f 30 to allow s ta tis tica l analysis. Figure 15 
shows the d is tribu tion  curves fo r fib ronectin  level in the young and 
elderly healthy populations in the present study.
Table 3
Accuracy and precision o f the fib ronectin  assay
at varying reaction volumes.
1000 fil 300 [il 25 fil
Fibronectin
(mg f 1) n mean c.y mean CV. mean C.V
1000 5 0.286 9 .3 0.274 8 0.291 10.75
750 5 0.254 4 .9 0.261 5 .5 0.254 4 .5
500 5 0.193 5 .3 0.184 5.10 0.189 6 .3
250 5 0.091 11 0.092 10.5 0.087 13.6
125 5 0.042 20 0.045 22 0.0043 28
62.5 5 0.018 37 0.016 54 0.009 49
Table 4
Accuracy and precision o f the fib ronectin  assay
at varying antiserum dilutions using cryoprecip ita te  as a standard.
F ibronectin (mg I- '*')
Calculated Standard Assay M odified Assay* M odified Assay#
Fibronectin n Mean C.V. Mean C.V. Mean C.V.
1050 5 901 9.08
840 5 888 7.0
700 5 750 5.94 780 9.9
600 5 629 5.04 662 8.16
525 5 516 5.9 556 6.9
420 5 400 5.0 448 6.7
350 5 348 4.72 339 4.9
262 5 255 7.34 255 4.8 311 10.12
210 5 214 9.67 215 5.2 227 7.88
175 5 166 11.7 164 6.9 190 7.2
150 5 141 10.1 151 6.3 167 7.2
131 5 117 10.3 145 5.4 139 5.9
116 5 86 13.9 99 6.58 117 4.8
105 5 81 18.7 96 10.06 102 5.5
84 5 55 19.3 76 11.76 80 9.8
74 5 40 25 66 14.57 66 12.4
52.5 5 31 31 52.5 15.87 44 14.8
35 5 25 20.18 31 13.5
26.5 5 17 33.5 20 20.9
*
#
1 : 21 d ilu tion o f the antiserum
1 : 31 d ilu tion  o f the antiserum
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Comparison of the coefficient of variation for the immunoturbidi metric fibronectin 
assay, utilising 3 different dilutions of fibronectin antiserum (1:11), 1:21) and (1:31) 
Serial dilutions was carried out on a known concentration of human Cryoprecipitate. 
Each sample was assayed five times for fibronectin.
Table 5
Accuracy and precision o f the fib ronectin  assay
at varying antiserum dilutions using plasma as a standard.
F ibronectin (mg 1"^)
Calculated Standard Assay M odified Assay* M odified Assay#
Fibronectin
n mean C.V. mean c.v. mean CV.
410 5 394 4.15 433 5.08
273 5 259 4.81 269 3.8 305 8.59
203 5 195 8.1 190 4.2 222 7.22
166 5 149 8.0 159 6.0 176 6.7
133 5 118 9.34 138 7.5 433 6.08
102 5 79 11.32 97 8.6 106 6.18
82 5 58 15.66 71 10.4 85 9.3
35 5 31 20.42 45 11 48 11.8
41 5 28 15.9 29 14.4
27 5 16 26.1 16 26.11
*  1 : 21 d ilu tion  o f the antiserum
# 1 : 31 d ilu tion o f the antiserum
Figure 10
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Comparison of the coefficient of variation for the immunoturbidi metric 
fibronectin assay, utilising three different dilutions of fibronectin antiserum 
(1:11,1:21 and 1:31). Serial dilution was carried out on a known concentration 
of human plasma fibronectin. Each sample was assayed five times.
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plasma fibronectin.
Table 6
The e ffe c t o f heparin on plasma fib ronectin  estim ations. 
Plasma fib ronectin  (mg 1” ^)
Patient Venous Sample A rte ria l sample
1 243 258
2 184 156
3 225 210
4 286 278
3 300 275
mean 248 235.4
S.D. 46.9 52.6
Venous sample v. a rte ria l sample -  not s ig n ifica n t*  
*  Student’s t  test (paired)
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E ffec t o f Surgery on Plasma Fibronectin
As most o f the patients adm itted to  Intensive Care in septic shock 
have undergone surgery, i t  was im portant to determ ine the e ffe c t 
th is m ight have had on th e ir plasma fib ronectin . Accordingly 
patients undergoing e ither routine or emergency laparotomy (except 
fo r appendicectomy) had blood samples taken on the pre-operative 
day, or during the imm ediate pre-operative period, and on the f ir s t ,  
fou rth  and eighth post-operative days, fo r estim ation o f plasma 
fib ronectin . In to ta l, 199 patients were studied. The results are 
shown in Figure 16, which also shows separately the results from  19 
patients who subsequently died. The mean pre-operative value fo r 
the group as a whole was 325 mg f ^ .  The level had fa llen  
s ign ifican tly  by the f irs t  post-operative day, i t  remained low on the 
fourth  post-operative day but returned to  normal by the eighth. In 
the patients who did not survive, the pre-operative level (275 mg 1” ^) 
was s ign ifican tly  below the mean fo r the group as a whole. Again the 
level fe ll post-operatively but showed no reversal by the eighth. 
Figure 17 shows the d istribu tion  curves fo r fib ronectin  on each o f the 
days studied.
E ffe c t o f Sepsis on Plasma F ibronectin
Patients adm itted to  Intensive Care w ith  a diagnosis o f sepsis but 
who were not in shock had plasma fib ronectin  levels measured tw ice  
a day throughout th e ir stay in Intensive Care. Patients were divided 
in to non-survivors (Figure 18) and survivors (Figure 19). Both groups 
showed a fa ll in plasma fib ronectin , but the survivors showed a 
reversal o f th is trend as th e ir condition improved.
Figure 16
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Serum plasma fibronectin levels in patients with severe sepsis who survived.
C ryoprecip ita te  Replacement o f F ibronectin in Septic Shock
This study was designed to  look, f ir s t,  at the e ffec ts  o f septic shock 
on hepatic metabolism, plasma fib ronectin  and c ircu la ting  endotoxin 
and, secondly, to  evaluate the use o f cryoprecip ita te  as a source o f 
fib ronectin  in the trea tm ent o f septic shock.
Entry c r ite r ia
The patients in this study were a ll inpatients in the Intensive Care 
U n it o f the Western In firm ary , Glasgow. The c r ite r ia  fo r admission 
to  the study were as fo llow s:-
Proven septicaemia or a proven m ajor source o f sepsis
w ith
Systolic blood pressure less than 90 mm Hg. 
and
O liguria (less than 30 m l hr"'*'), 
and
Core/peripheral tem perature gradient over 4°C.
and
C lin ica l features o f shock 
tachypnoea, tachycardia, confusion and pa llo r.
Admission procedure
Patients meeting these c r ite r ia  were prospectively randomised by a 
closed envelope technique to e ither a contro l or trea tm ent group. 
Both groups received routine Intensive Care therapy and, in add ition, 
the trea tm ent group (hereafter re fe rred to as cryoprec ip ita te  group) 
received an infusion o f cryoprecip ita te  o f a volume calculated to  
raise the plasma fib ronectin  level above 300 mg I"'*'. C ryoprec ip ita te
was subsequently given whenever the fib ronectin  level fe ll to  less 
than 200 mg 1~\ u n til the patients consumption o f fib ronectin  
decreased and the plasma fib ronectin  level remained stable in the 
normal range (or u n til the patients le f t  the Intensive Care U n it). On 
the f ir s t  day o f trea tm en t, patients in the contro l group received an 
infusion o f plasma prote in solution equivalent in volume to the 
infusion o f cryoprecip ita te  tha t would have been given had the 
pa tien t been in the cryoprec ip ita te  group. Plasma prote in solution 
can be regarded as cryoprecip ita te -deple ted plasma ( it  has a mean 
fib ronectin  level o f 15 mg 1” ^). On subsequent days, because the 
fib ronectin  level in the con tro l group remained low, i t  was obviously 
inappropriate to calculate the volume o f plasma prote in solution to  
be given in the same way. However, since the volume o f 
cryoprecip ita te  given to  a patient in the trea tm ent group on average 
was 400 mis, this volume o f plasma prote in solution was given on a 
daily basis to patients in the contro l group. These volumes o f co llo id  
given to  the two groups were allowed fo r  by the consultants in charge 
when calculating the pa tien t’s flu id  requirements fo r the day.
Investigations carried out on admission
1. Plasma fib ronectin  level
2. Indocyanine green clearance
3. Antipyrine clearance
4. Plasma endotoxin level
5. Blood cultures
6. A fu ll range o f physiological measurements including pulse,
blood pressure, core and peripheral tem perature, cardiac
output, a rte ria l and mixed-venous blood gases, pulmonary
arte ry  pressure, pulmonary a rte ry  wedge presure, cen tra l 
venous pressure and urine output
7. Sepsis score and APACHE II score
8. Routine laboratory tests i.e. b iochem istry, haematology, 
bacterio logy and blood cross matching.
Subsequent investigations
1. Plasma fib ronectin  levels were measured four-hourly  
throughout the study period in both the con tro l and 
cyroprec ip ita te  groups. The cryoprec ip ita te  group also had 
fib ronectin  levels measured im m ediate ly before 
cryoprec ip ita te  infusion and 30 to  60 minutes a fte rw ard . The 
contro l group had fib ronectin  levels measured before and 30 to  
60 minutes a fte r the infusion o f plasma protein solution tha t 
was given in lieu o f cryoprecip ita te
2. Endotoxin measurements; these were in it ia lly  perform ed fo u r- 
hourly while the patients were unstable. They were also 
perform ed before and a fte r the infusion o f cryoprec ip ita te  or 
plasma protein solution. (Obtaining samples fo r endotoxin 
measurement depended on reasonable peripheral venous access 
since these samples cannot be drawn from  indwelling vascular 
lines)
3. Indocyanine green clearance was measured eight-hourly
4. The fu ll range o f physiological measurements, as lis ted above, 
were carried out four-hourly and, in addition, before and a fte r 
collo id  infusion
5. Blood cultures were perform ed at least daily
Results
Table 7 shows com parative data fo r  the contro l and cryoprec ip ita te  
groups at the tim e o f entry to the study, i t  can be seen tha t the 
groups were w e ll matched fo r  a ll the c r ite r ia  examined. Both the 
APACHE II score and Sepsis Score indicate tha t the pro toco l had 
selected an extrem ely sick group o f patients.
Selected Case H istories
R.McD. 45 years. Male. Gram-negative septicaem ia fo llow ing 
traum a. Contro l group. Non survivor.
This pa tien t had been adm itted to  Intensive Care fo llow ing m u ltip le  
traum a; his in juries included chest traum a, m u ltip le  long bone 
fractures and traum atic  amputation o f one arm. He developed a 
proven Gram-negative septicaemia a fte r seven days in Intensive 
Care, presumed to  have come from  a pulmonary source. Figure 20 
shows a p ro file  o f measurements made fo r th is pa tien t. Plasma 
fib ronectin , indocyanine green clearance, cardiac output, urine 
output, core tem perature and plasma endotoxin are p lo tted  against 
tim e . The in it ia l fib ronectin  level o f 140 mg 1"^ rap id ly fe l l  to  below 
100 and remained at tha t low level u n til he succumbed. The values 
fo r indocyanine green clearance were low (normal being 1000-1300 
mis m in- ^) pa rticu la rly  when the high cardiac output is taken in to  
account. He was anuric and remained pyrexia l u n til his death. 
S ignificant levels o f endotoxin were present in the plasma and 
climbed steadily.
T.B. 61 years. Male. Staphylococcus aureus septicaem ia from
prosta tic  abscess. C ontro l group. Survivor.
This patient was adm itted to  Intensive Care d irec t from  theatre  
having gone in to septic shock during the operative drainage o f a 
p rosta tic  abscess. Staphylococcus aureus was subsequently isolated 
from  both the abscess pus and the blood stream. Figure 21 shows the 
p ro file  fo r this pa tien t. The in it ia l plasma fib ronectin  leve l o f 230 
mg f 1 fe ll to  100 mg 1” ^ but returned to the normal range before the 
patient's discharge from  Intensive Care. The indocyanine green 
clearance values were close to  norm al, cardiac output was high and 
urine output rose to  normal a fte r a period o f anuria im m ediate ly 
fo llow ing admission. The patient's haemodynamic status stabilised 
fo llow ing early resuscitation. The fo llow ing day, however, there was 
a second cardiovascular collapse, at which tim e a high peak o f 
endotoxaemia (100 pg m l” '*') was observed, as shown in Figure 21. The 
patient again stabilised rapid ly and le f t  Intensive Care the fo llow ing 
day.
D.B. 31 years. Female. Necrotisinq fa sc iitis . C ryoprec ip ita te  
group. Non survivor.
This pa tien t was adm itted to  Intensive Care in profound septic shock 
secondary to necrotising fa sc iitis . She was never su ffic ie n tly  w e ll to  
allow  surgical debridement to  be carried out. Her in it ia l fib ronec tin  
level o f 80 mg 1"^ was raised fo llow ing the infusion o f 25 units o f 
cryoprec ip ita te , but, as can be seen from  Figure 22, th is fib ronec tin  
was rapid ly consumed, necessitating a fu rthe r infusion o f 
cryoprec ip ita te  soon a fte r. Indocyanine green clearance started  a t a 
low level and deteriorated. The patient was in it ia lly  hyperdynam ic 
but the cardiac output la te r fe ll.  High c ircu la ting  levels o f endotoxin
were present throughout, the levels steadily rising u n til the tim e  o f 
death.
I.M cD. 36 years. Female. Necrotisinq fa sc iitis . C ryoprecip ita te  
group. Survivor.
This d iabetic lady was adm itted to  Intensive Care in profound septic 
shock and fo llow ing stabilisa tion was taken to theatre fo r surgical 
debridement o f the involved fascia. Figure 23 shows her p ro file . The 
in it ia l fib ronectin  level o f 125 mg 1” ^ was raised to  over 400 mg I - "*- 
by the infusion o f 20 units o f cryoprec ip ita te . Indocyanine green 
clearance was in it ia lly  low but improved s ligh tly  over the course o f 
the patient's stay. She had a s ligh tly  elevated cardiac output and a 
low level o f pyrexia, which settled a fte r several days. High levels o f 
endotoxin were present in the plasma throughout the f ir s t  few  days, 
but a decrease in th is level o f endotoxaemia was frequently observed 
fo llow ing the infusion o f cryoprec ip ita te , as can be seen from  Figure 
23. The patient's stay in Intensive Care was prolonged and she had a 
high requirem ent fo r cryoprecip ita te  infusion over a considerable 
length o f tim e . The p lo t o f fib ronectin  levels show tha t the ra te  o f 
removal o f fib ronectin  from  the plasma gradually decreased as her 
condition stabilised. A t the end o f the tim e period covered by Figure 
23 the patient was discharged to  another hospital. Her fib ronectin  
level at th is stage had stabilised but was s t i l l  low; her core 
tem perature had also risen again fo llow ing a period o f apyrexia and 
th is was in terpreted as being due to low grade sepsis in some o f the 
surgical wounds. In te rm itte n t samples taken in the hospital to  which 
she was transferred showed tha t the fib ronectin  level eventually rose 
spontaneously back to  the normal level.
Q.E. 28 years. Male. Staphylococcus aureus septicaemia from
septic a r th r itis . C ryoprecip ita te  group. Survivor.
This pa tien t was adm itted to  Intensive Care w ith  a staphylococcal 
septicaemia secondary to septic a rth r itis  which developed fo llow ing 
an arthroscopy and knee exploration. He was in it ia lly  extrem ely i l l  
and haemodynamically very unstable but improved a fte r three to four 
days and subsequently survived. His in it ia l fib ronectin  level o f 120 
mg I-1 was raised by the infusion o f c ryoprec ip ita te . Again the 
p ro file  in Figure 24 shows tha t the ra te  o f consumption o f fib ronectin  
gradually decreased as the pa tien t’s condition improved; the volumes 
o f cryoprec ip ita te  required gradually decreased and he was 
eventually weaned from  cryoprec ip ita te  infusion on the f i f th  day. 
Follow ing th is , the fib ronectin  level stabilised, then rose back to  
w ith in  the normal range. Indocyanine green clearance was in it ia lly  
extrem ely low and remained low fo r five  days before gradually 
im proving. Again, th is patient had in te rm itte n t peaks o f 
endotoxaemia, which appeared to  fa ll fo llow ing cryoprec ip ita te  
infusion. (The presence o f these peaks o f endotoxaemia in patients 
Q.E. and T.B., both o f whom had Gram -positive septicaem ia, w ill be 
commented on la te r in the discussion section).
The E ffe c t o f C ryoprecip ita te  and Plasma Protein Solution Infusions 
on a Variety o f Physiological and Biochemical Variables
The cryoprec ip ita te  infusions, and the plasma prote in solution given 
to  contro l patients in lieu o f cryoprec ip ita te , were given as pa rt o f 
the patient's flu id  requirements, and not in addition to  those 
requirements. The ra te  o f infusion was adjusted so as not to  a lte r the 
pulmonary a rte ry  wedge pressure. Tables 8 and 9 show a range o f
variables measured before and 30 to  60 minutes a fte r infusion o f 
e ithe r plasma prote in solution (Table 8) or cryoprec ip ita te  (Table 9). 
Follow ing cryoprec ip ita te  there was, as expected, a s ign ifican t rise in 
plasma fib ronectin  levels. An improvement in urine output and a fa ll 
in the level o f pyrexia were also observed, both o f these changes 
being s ign ifican t. In te resting ly, there was also a s ign ifican t fa ll in 
the level o f endotoxaemia. There was a tendency fo r indocyanine 
green clearance to improve and fo r pulmonary vascular resistance to  
fa ll,  although neither o f these changes achieved s ta tis tic a l 
s ignificance.
Follow ing plasma prote in solution infusion no s ign ifican t change was 
observed in any o f the variables measured.
Indocyanine Green Clearance from  Plasma
For the method used to calculate indocyanine green clearance see 
Page 38 . Table 10 shows the mean in it ia l indocyanine green 
clearance and mean 24-hour indocyanine green clearance fo r a ll the 
patients in the septic shock study; values are also given separately 
fo r the contro l and cryoprecip ita te  groups and fo r survivors and non- 
survivors. The mean in it ia l indocyanine green clearance fo r  a ll 
patients was 688 m l m in“ \  which was s ign ifican tly  lower than the 
accepted normal value o f greater than 1200 m l m in- '*'. The in it ia l 
values were lower in the cryoprecip ita te  group than in the con tro l 
group but th is d iffe rence did not achieve s ta tis tica l s ignificance; nor 
was there any s ign ifican t d ifference between the in it ia l values fo r 
the survivors versus non-survivors. O f the seven patients who 
survived, a ll but two showed an improvement in clearance over the
f ir s t  24 hours; o f the sixteen who died, a ll but one showed a 
de te rio ra tion . Such changes may therefo re  have a prognostic value.
A n tipyrine  H a lf-L ife
Table 11 shows the results o f antipyrine h a lf- life  analysis fo r a ll the 
patients in the septic shock study. The normal antipyrine h a lf- life  in 
plasma fo r healthy subjects is in the region o f 10 hours (Boobis et_al, 
1980); the mean antipyrine h a lf- life  in the septic shock patients was 
s ign ifican tly  prolonged at 28.7 hours. There were no s ign ifican t 
d ifferences between the contro l and cryoprec ip ita te  groups or 
between survivors and non-survivors.
Outcome in Septic Shock Study
For the purpose o f th is study, m o rta lity  was defined as to ta l hospital 
m o rta lity  and not merely m o rta lity  w ith in  the Intensive Care U n it. 
Table 12 shows the details o f randomisation and outcome in the 
contro l and cryoprecip ita te  groups. In to ta l, 23 patients were 
included in the study: o f the eleven in the contro l group, tw o 
survived; and o f the twelve in the cryoprec ip ita te  group, five  
survived. This m o rta lity  d ifference did not achieve s ta tis tic a l 
significance when tested by Chi-squared analysis. Figure 25 shows a 
p lo t o f the cum ulative m o rta lity  fo r each group against tim e . There 
were more early deaths in the contro l group than in the 
cryoprec ip ita te  group and this d iffe rence in m o rta lity  was s ign ifican t 
on day 2 and day 3. Using Fishers' exact analysis, the P values were
0.03 fo r day 2 and 0.01 fo r day 3.
Table 7
Comparative data fo r contro l and cryoprecip ita te  groups 
in the septic shock study.
C ontro l C ryoprecip ita te  P
Group Group Value*
mean + S.D. mean + S.D.
Age 56 + 10.1 54 + 13.6 N.S.
Sex M : F 6 + 5 5 + 7 N.S.
Mean Blood Pressure 
(mm Hg) 52 + 7.5 55 + 11.6 N.S.
Pulmonary Shunt 0.13+ 0.06 0.14+ 0.07 N.S.
A - a Gradient 
(mm Hg) 246.9 + 69.7 266.6 + 98.6 N.S.
Plasma Fibronectin 
(mg I " 1) 127.6 + 69.4 97.0 + 35.6 N.S.
Indocyanine Green Clearance 
(ml m in"^) 766 + 497 589 + 364 N.S.
Apache II Score 19.3 + 3.1 21.5 + 5.9 N.S.
Sepsis Score 21.5 + 7.2 22 + 4.8 N.S.
*  Student’s t  test (unpaired)
N.S. not s ign ifican t
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Table 8
The e ffe c t o f plasma prote in solution on physiological variables.
Pre Infusion 
mean + S.D.
Post Infusion 
mean + S.D.
P Value
Urine Output 
(ml m in” 1) 53 + 70.2 40 + 47 N.S.
Core Temperature 
(0°C) 38.23 + 1.16 38.07 + 1.24 N.S.
Indocyanine Green Clearance 
(ml m in” 1) 564 + 434 516 +426 N.S.
Cardiac Output 
(1 m in” 1) 9 .39+ 2.83 9.08+ 1.88 N.S.
Pulmonary A rte ry  Wedge Pressure 
(mm Hg) 11.21+ 4.66 10.95+ 3.35 N.S.
Pulmonary Vascular Resistance 
(dyne, sec cm’ ^) 88.6 + 55.2 93.6 + 73.6 N.S.
Endotoxin 
(pg m l” 1) 15.8 + 12.29 25.23 + 23.44 N.S.
Plasma Fibronectin 
(mg I” 1) 117.1 + 32.4 125 + 72.1 N.S.
Mean Blood Pressure 
(mm Hg) 67.6 + 13.3 69.8 + 18.3 N.S.
*  Student's t  tes t (paired)
N.S. not s ign ificant
Table 9
The e ffe c t o f cryoprec ip ita te  on physiological variables.
Mean values fo r a ll infusions given to  a ll patients in cryoprec ip ita te  group.
Pre Infusion 
mean + S.D.
Post Infusion 
mean + S.D.
P Value*
Urine Output 
(ml m in"1) 77.7 + 49.6 123.7 + 75.5 = 0.001
Core Temperature 
(0°C) 38.3 + 1.2 37.9 + 0.9 < 0.05
Indocyanine Green Clearance 
(m l m in"1) 734 + 419 818 + 464 N.S.
Cardiac Output 
(1 m in"1) 8.4 + 2.44 8.19+ 2.36 N.S.
Pulmonary A rte ry  Wedge Pressure
(mm Hg) 14.52 + 4.04 13.91+ 3.86 N.S.
Pulmonary Vascular Resistance 
(dyne, sec cm "'’ ) 89.6 + 43.2 63.8 + 27.2 N.S.
Endoxotin 
(pg m l"1) 86.25 + 77.82 40.8 + 49.5 < 0 .0 5
Plasma F ibronectin 
(mg I " 1) 166.4 + 59.45 432 + 58.5 > 0 .0001
Mean Blood Pressure 
(mm Hg) 74.72+ 10.9 77.6 + 11.84 N.S.
*  Student's t  tes t (paired)
N.S. not s ign ifican t
Table 10
Indocyanine green clearance (ICG) from  plasma 
in septic shock study patients.
In it ia l values were at tim e o f randomisation to study.
In it ia l ICG 
clearance
mean + S.D.
24 hour ICG 
clearance
mean + S.D.
P va lue*
C ontro l group 
(n = 11) 733 533 612 478 <  0.05
C ryoprecip ita te  group
(n = 12) 589 362 577 331 N.S.
Overall 688 436 622 387 < 0 .0 5
Survivors 
(n = 7) 548 297 648 331 N.S.
Non-survivors
(n = 16) 721 512 562 440 <  0.01
*  Student's t  test (unpaired)
In it ia l ICG clearance 24 hour ICG clearance
contro l v. cryoprecip ita te  N.S. contro l v. cryoprec ip ita te  N.S.
survivors v. non-survivors N.S. survivors v. non-survivors N.S.
N.S. not s ign ifican t
Table 11
A ntipyrine h a lf- life  in septic shock patients.
Antipyrine h a lf- life  (hrs) 
mean + S.D.
P Value*
C ontro l group 
(n = 11) 32.1 + 12.6
N.S.
C ryoprecip ita te  group 
(n = 12) 24.9+ 7.0
N.S.
A ll patients 
(n = 23) 28.7 + 10.7
Survivors 
(n = 7) 25.3+ 9.4
Non-survivors
(n = 16) 30.4 + 11.21
N.S.
*  Student's t  tes t (unpaired) 
N.S. not s ign ifican t
Table 12
M o rta lity  data fo r septic shock study.
C ontro l group C ryoprecip ita te  group
n 11 12
survivors 2 5
non-survivors 9 7
C ontro l group v. C ryoprecip ita te  group -  not s ig n ifica n t*  
*  Chi square test
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Summary o f C lin ica l Studies
The results described above could be summarised by saying th a t the
adm in istra tion o f cryoprec ip ita te  to  patients in septic shock:
1. does, as one would antic ipate , raise the plasma fib ronectin  
level;
2. increases output o f urine approxim ately tw o fo ld ;
3. probably, but less ce rta in ly , reduces plasma endotoxin levels 
and brings core tem perature a l i t t le  closer to normal;
4. probably produces a modest improvement in live r function  as 
re flec ted  by indocyanine green clearance;
3. does not, however, improve the impaired capacity to
metabolise antipyrine; and,
6. may improve survival.
CHAPTER 5
THE OBSERVATIONS ON ANIMAL EXPERIMENTS
The E ffe c t o f Endotoxin on Rats
One o f the most s trik ing  observations in the c lin ica l studies was tha t 
the septic shock patients had a greatly  impaired a b ility  to  clear 
antipyrine. This seemed to  m erit fu rthe r investigation in animals. 
An tipyrine is norm ally taken up in the live r and oxidised by the 
microsomes. I t  seemed o f in terest to  establish whether the 
im pairm ent o f th is process in septic shock was due to the endotoxin 
in some way diminishing m icrosomal function . This was investigated 
in ra ts.
P re lim inary studies were carried out to  assess the e ffe c t o f storage 
and the e ffe c t o f morphine adm in istration on the m icrosom al 
cytochrome a c tiv ity  in the live r. A t the same tim e , corticostero id  
response to the surgical stress o f cannulation was measured in order 
to  determ ine the length o f tim e  required fo r stab ilisa tion.
E ffe c t o f Storage at -7Q°C on hepatic m icrosomal cytochrom e 
a c tiv ity
Five healthy animals were sacrificed by cerv ica l dislocation w ithou t 
p rio r instrum entation or anaesthesia. The liv e r was removed and 
divided in to four parts. Three o f the four were frozen in liqu id  
nitrogen and subsequently stored at -70^C. The remaining pa rt was 
placed on ice and the m icrosomal preparation and cytochrome assays 
carried out im m ediate ly. The stored samples were removed fo r
microsomal preparation and cytochrome determ ination a fte r  6, 12 
and 24 weeks. Table 13 shows the results; storage had no e ffe c t on 
the a c tiv ity  o f any o f the cytochrome enzymes measured.
E ffe c t o f morphine on hepatic m icrosomal cytochrome a c tiv ity  
In the main experim ent, morphine sulphate was to  be given as an 
analgesic a fte r the im plantation o f cannulae. In order to assess the 
e ffe c t, i f  any, on cytochrome a c tiv ity , two groups, each o f five  ra ts, 
were used. One group received 100 [jug o f morphine sulphate 
intravenously while the other group received saline. F o rty -e igh t 
hours la te r the animals were sacrificed , the livers removed and 
hepatic m icrosomal cytochrome a c tiv ity  assayed. The results are 
shown in Table 14 I t  can be seen tha t morphine had no discernible 
e ffe c t.
E ffe c t o f surgical stress on ra t plasma corticosterone levels 
Five rats were subjected to the surgical procedure described on Page 
4 8  and blood samples were w ithdrawn through the jugu lar line 
im m ediate ly a fte r surgery, and 4, 24, 48 and 72 hours la te r, fo r  
measurement o f plasma corticosterone levels. Figure 26 shows the 
results obtained. Corticosterone levels were very high at tim e  zero 
and a t 4 hours, but fe ll rap id ly the rea fte r. In the main experim ent, a 
stabilisa tion period o f 48 hours was chosen as a compromise between, 
on the one hand, allowing stress (as re flec ted  in corticosterone levels) 
to  subside and, on the other, avoiding the risk o f blood c lo ttin g  in the 
cannulae.
Table 13
The e ffe c t o f storage a t -70°C  on ra t hepatic cytochrome a c tiv ity .
Time from  sacrifice
0 6 wks* 12 wks* 24 wks*
n 3 5 5 5
Cytochrome P450 
(n mol mg pro te in ” '*')
mean
S.D.
0.91
0.054
0.97
0.046
0.94
0.063
0.90
0.027
Cytochrome b5 
(n mol mg pro te in ” '*')
mean
S.D.
0.39
0.041
0.37
0.031
0.41
0.028
0.38
0.026
NADPH cytochrome c reductase 
( jttmol min"'*' mg pro te in ” '*')
mean
S.D.
0.126
0.018
0.119
0.026
0.123
0.017
0.128
0.009
NADH cytochrome c reductase 
CjLtmol m in” '*' mg pro te in ” '*')
mean
S.D.
0.096
0.02
0.099
0.016
0.093
0.022
0.101
0.014
o
Samples stored at -70 C
Table 14
The e ffe c t o f morphine on ra t hepatic cytochrome a c tiv ity .
Saline Morphine
Cytochrome P430 
(n mol mg pro te in ” '*')
Cytochrome b5 
(n mol mg p ro te in ” '*')
NADPH cytochrome c reductase 
( f l m ol m in” '*' mg pro te in ” '*')
NADH cytochrome c reductase 
C/xmol m in” '*' mg pro te in ” '*')
n 5 5
mean 0.94 0.99
S.D. 0.046 0.053
mean 0.44 0.41
S.D. 0.029 0.022
mean 0.116 0.124
S.D. 0.022 0.017
mean 0.104 0.095
S.D. 0.016 0.023
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E ffe c t o f endotoxin and hypovolaemic shock oq  hepatic m icrosomal 
cytochrome a c tiv ity
This experim ent was designed to  tes t the e ffe c t o f varying doses o f 
endotoxin on hepatic m icrosomal cytochrome a c tiv ity , w ith  a view to  
distinguishing the haemodynamic and m etabolic e ffec ts  o f endotoxin. 
Twenty rats were used as contro ls. Following line insertion and a 48- 
hour stab ilisa tion period, they each received a 0.5 m l infusion o f 0.9% 
saline intravenously over 4 hours. Four animals were sacrificed a t 
each o f the fo llow ing tim e  in terva ls: 5, 10, 20, 30 and 50 hours. The 
livers were removed and stored fo r m icrosomal cytochrome assay. 
Table 15 shows the results o f the cytochrome assays and the mean 
a rte ria l pressure readings. There are no s ign ifican t changes in e ithe r.
The rats who received endotoxin also had a fo rty -e ig h t hour
stabilisa tion period fo llow ing line insertion. They were grouped
according to  the does o f endotoxin administered w ith  12 ra ts in each
group. The doses o f endotoxin were:-
5 x 10^ mg kg""*"
5 mg kg"’’*'
5 x 10” '*' mg kg” "*"
5 x 10"2 mg kg""*'
5 x 10“ ^  mg kg- **"
5 x 10“ 4 mg kg- "*-
5 x 10“ 5 mg kg- '*'
Two animals were sacrificed at each o f the fo llow ing tim es: 5, 10, 20 
and 50 hours from  the s ta rt o f the endotoxin infusion. None o f the 
animals receiving 5 x 10^ mg k g - l survived to  10 hours, so the results 
fo r the animals sacrificed a t 5 hours are shown in Table 16. For each 
o f the other endotoxin doses, the results o f the cytochrome a c t iv ity
assay and blood pressure measurement are shown graphically in 
Figures 27 to  32.
The larger doses o f endotoxin (down to  30 mg kg’ ^) produced a 
consistent fa ll in mean a rte ria l pressure and a roughly para lle l fa ll in 
the cytochromes. These e ffec ts  were diminished as the dose was 
reduced (Table 16, Figures 27, 28 and 29). Lower doses o f endotoxin 
had no consistent e ffe c t (Figures 30, 31 and 32). The remarkable 
paralle lism  between blood pressure and cytochrome a c tiv itie s  
im m ediate ly raises the question whether the fo rm er is determ ining 
the la tte r .  To test th is, a fu rthe r group o f tw elve ra ts were 
subjected to  hypvolaemic shock by w ithdraw al o f 2 m l o f blood a t 0,5 
and 10 hours, i.e . 6 m l in to ta l. The results are shown in Figure 33. 
The loss o f blood resulted in a precip ita tous fa ll in mean a rte ria l 
pressure, but this was not accompanied by comparable fa lls  in 
cytochrome ac tiv itie s .
Figure 34 summarises the e ffec ts  o f the various doses o f endotoxin
and hypovolaemic shock on blood pressure and hepatic m icrosom al
cytochrome a c tiv ity . From the results, i t  appears tha t cytochrome
P450 is more sensitive than the other cytochromes measured to  the
e ffe c t o f endotoxin. I t  was not only reduced by a greater percentage
at each dose but was also a ffected by sm aller doses o f endotoxin than
the other cytochromes. A fa ll in mean a rte ria l blood pressure was
-2  -1observed down to and including 5 x 10 mg kg o f endotoxin. In
doses sm aller than th is, no change in blood pressure was observed; but
cytochrome b5 a c tiv ity  was s t il l reduced at 5 x 10"^ mg kg~^ and
cytochrome P450 a c tiv ity  was reduced at 5 x 10"^ and 5 x 10"^ mg 
kg-1. The induction o f hypovolaemia produced a marked fa ll in blood
pressure, but only m inim al changes in cytochrome a c tiv ity . Thus the
haemodynamic and m etabolic e ffe c t o f endotoxin can be separated, 
and the reductions observed in cytochrome a c tiv ity  appear to  be, at 
least in part, independent o f the associated hypotension.
These observations are consistent w ith  the lim ite d  in fo rm ation  in the 
lite ra tu re : the con tro l value obtained fo r  the cytochrome P430 assay 
agrees w ith  the results o f Takeda et al (1984) and Falzon e t al 
(1984). The cytochrome b5 results agree w ith  those o f Takeda et al 
(1984). F ina lly , Takeda et al (1984) induced sepsis in ra ts by caecal 
liga tion  then measured cytochrome a c tiv ity  fo llow ing sacrifice  a t 72 
hours. They found reductions in cytochromes P450 and b5 and also 
NADPH cytochrome c reductase o f a s im ila r magnitude to  those seen 
in the present study in the group o f rats receiving 5 mg kg"'*' o f
endotoxin when sacrificed at 50 hours. (Figure 27).
Conclusion
I t  is apparent tha t endotoxin does im pair the a c tiv ity  o f live r
m icrosomal cytochromes, especially o f cytochrome P450, and th a t 
th is is not secondary to  the concom itant fa ll in mean a rte ria l
pressure.
Table 15
Rat cytochrome a c tiv ity  and blood pressure fo llow ing saline adm in istra tion.
Sacrifice tim e (hours) from  s ta rt 
5 10 20 30 50
Cytochrome P450 
(n m o l mg protein"'*')
mean 0.95 0.98 0.92 0.95 0.96
S.D. 0.061 0.064 0.054 0.026 0.066
Cytochrome b5 
(n mol mg protein""*")
mean 0.42 0.39 0.42 0.44 0.46
S.D. 0.026 0.033 0.033 0.041 0.046
NADPH cytochrome c reductase mean 0.137 0.125 0.125 0.13 0.115
OjCtmol min""*" mg protein"'*') S.D. 0.018 0.021 0.015 0.26 0.02
NADH cytochrome c reductase mean 0.098 0.115 0.105 0.108 0.10
(/xm ol min""*" mg protein""*") S.D. 0.021 0.014 0.019 0.011 0.015
Mean a rte ria l blood pressure 
(mm Hg)
mean 110 108 115 106 110
S.D. 8.46 3.68 6.73 7.76 9.12
Table 16
Rat cytochrome a c tiv ity  and blood pressure 
fo llow ing endotoxin (5 x 10 mg kg” ) adm in istra tion.
Cytochrome P450
% o f con tro l 56
Cytochrome b5
% o f con tro l 81
NADPH cytochrome c reductase 
% o f contro l 85
NADH cytochrome c reductase 
% o f con tro l 31
Blood pressure
% o f contro l 62
Figure 27
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Experim entally Induced Septic Shock in Pigs
Quite apart from  the questions o f antipyrine clearance and 
cytochrome P450 a c tiv ity  described in the preceding section, the 
c lin ica l studies raised a number o f issues which seemed to  m erit 
investigation in experim ental animals. One o f the most puzzling o f 
these was tha t in some patients indocyanine green clearance was 
found to  be very low, yet at autopsy or a t laparotomy there was no 
evidence o f ischaemia o f the gut such as would be expected in the 
presence o f a g reatly  reduced hepatic blood flow . This m ight point to  
a fa ilu re  on the part o f the live r to  clear indocyanine green a t its  
normal high ra te  o f extraction . (In normal subjects 90% o f the 
indocyanine green present in the blood is removed in a single passage 
through the live r). Such a hypothesis would be consistent w ith  the 
evidence given in the preceding section fo r the e ffe c t o f endotoxin in 
inh ib iting some aspects o f live r metabolism . A second question arose 
in re la tion  to  the low levels o f fib ronectin  found in septic shock; were 
these evidence o f impaired synthesis, on the one hand, or more rapid 
rem oval, on the other? To answer these and re la ted questions, a 
study was undertaken o f experim enta lly induced septic shock in the 
pig. The pig was chosen because a large animal model was required 
to allow a fu ll range o f instrum entation, and because, unlike the dog, 
i t  has a s im ila r splanchnic and porta l c ircu la tion  to  man. Before such 
a pro ject could be undertaken, two pre lim inary problems had to  be 
tackled: the fib ronectin  assay had to  be m odified fo r  use w ith  porcine 
plasma; and a muscle re laxant had to be selected which would not 
give rise to  a rte facts .
Development o f the im m unoturb id im etric  assay fo r porcine 
fib ronectin
Various dilutions o f human fib ronectin  antiserum in bu ffe r were 
reacted w ith  various volumes of standard concentrations o f purified  
porcine fib ronectin . For each reaction the op tica l density was read 
at in terva ls to  60 minutes (fo r fu ll details o f the d ilutions, standard 
concentrations, volumes and reaction tim es see Page 62 ). A 
selection o f the results obtained are shown in Figures 35, 36 and 37 to  
illu s tra te  the trends observed. Figure 35, in which the change in 
op tica l density against tim e is p lo tted at three d iffe re n t antiserum 
dilu tions, shows tha t the change in op tica l density is s im ila r w ith  both 
the 1 : 5 and 1 : 10 d ilu tions. A 1 : 20 d ilu tion  however, produces a 
much sm aller change in op tica l density. A 1 : 10 d ilu tion  was 
therefore  chosen fo r use in the assay. Likewise, in Figure 36, in 
which the change in op tica l density w ith  tim e  is p lo tted  fo r varying 
plasma volumes, the smallest volume o f plasma which could be used 
w ithou t a marked reduction in the change in op tica l density observed 
was 50 f i l .  This was therefore used in subsequent assays. Figure 37, 
shows th a t the reaction is v ir tu a lly  complete by 30 minutes and no 
benefit is obtained by fu rthe r prolongation o f the reaction tim e .
The selection o f a muscle re laxant
In a ttem pting to  obtain a stable haemodynamic p ro file  in the con tro l 
group, a number o f d iffe re n t muscle relaxants were tested. This 
proved necessary since pancuronium, the one orig ina lly  chosen, 
produced a marked increase in both heart ra te  and blood pressure. 
These e ffec ts  o f pancuronium and the other relaxants tested are
summarised in Table 17. Vecuronium was the only re laxant which had 
no e ffe c t on any haemodynamic measurements, making i t  the muscle 
re laxant o f choice.
Porcine septic shock model
The procedure followed is described in deta il in Page5 5  . A fte r  
insertion o f the necessary cannulae, the animals were le f t  fo r one 
hour to  stabilise, and then observed fo r a fu rthe r period o f ten hours 
(or u n til death), anaesthesia being maintained throughout. They were 
divided in to three groups:-
the control group received only an infusion o f 0.9% saline;
the E. coli group received an infusion o f Escherichia co li; and
the E. coli colloid group received an infusion o f Escherichia 
co li together w ith  su ffic ien t collo id to  m aintain pulmonary 
a rte ry  wedge pressure.
The survival o f the three groups is shown in Tables 18 and 19. The 
control group were a ll a live at the end o f the experiments. Those in 
the E» coli and E. coli colloid groups had a ll succumbed, but the la tte r  
had survived s ign ifican tly  longer than the fo rm er. Figure 38 shows 
the a rte ria l PC^. So fa r as possible, th is was maintained a t or above 
physiological levels by adjusting the concentration o f the inspired 
oxygen, but this proved impossible in the case o f the longest- 
surviving animals in the E. coli group. Figure 39 shows the core 
tem perature fo r the three groups: there were no s ign ifican t
differences between them . Figure 40 shows the heart ra te  in the 
three groups. In the control group i t  was, as one m ight hope and
expect, reasonably constant, whereas in the E. coli group i t  increased 
steadily u n til death supervened. The E. coli colloid group also showed 
a rise, but a fte r  four hours this fla ttened out and in the longest- 
surviving animals there was actually a tendency fo r the ra te  to fa ll 
back towards norm al. Figure 41 shows the mean a rte ria l pressure in 
the three groups. Again, in the control group i t  was almost constant 
throughout the experiment whereas in the E. coli group there was an 
im m ediate and sustained fa ll.  In the E. coli colloid group values 
fluc tua ted , but only a t the end o f the experiment did they fa ll 
s ign ifican tly  below the control group. Figure 42 shows the cardiac 
output in the three groups. Y e t again the con tro l values were quite 
constant. The E. coli group did not d iffe r  s ign ifican tly  from  the 
control group fo r the f ir s t  three hours, but the rea fte r output fe ll 
p rec ip ita te ly . In the E. coli colloid group there was an in it ia l rise 
above the contro l levels, which was sustained fo r  about five  hours. 
Thereafter the values observed were close to  the control group. 
Figure 43 shows the mean pulmonary a rte ry  pressure. Again in the 
control group th is was reasonably constant, although there was 
perhaps evidence o f a s light increase w ith  tim e . The E. coli group, in 
contrast, showed a jump w ith in  an hour to a value more than tw ice  
the normal, and this high level was sustained u n til death. The 
E. coli colloid group behave almost iden tica lly . In contrast, 
pulmonary a rte ry  wedge pressure (i.e. le f t  a r tr ia l pressure), shown in 
Figure 44, fe ll sharply in E. coli group animals while in the 
control group i t  remained steady and in the E. coli colloid group there 
was some evidence o f an increase towards the end o f the experim ent.
These haemodynamic observations lead to  several conclusions:-
1. The remarkably constant control group levels in each o f 
the figures give grounds fo r confidence th a t the 
control group are being successfully maintained in a 
stable condition and therefore a ffo rd  a secure basis to  
which the other groups can be re lated .
2. The E. coli group do indeed m anifest the classical 
features o f shock: tachycardia; fa lling  a rte ria l pressure; 
and fa lling  cardiac output. A ll these changes are to  
some degree prevented or reversed by the 
adm in istra tion o f co llo id . Presumably therefo re  they 
are a ll, in the main, consequences o f hypovolaemia.
3. One o f the most s trik ing  changes in the shocked animals 
was the sudden and sustained increase in pulmonary 
a rte ry  pressure. This was not a ffected  by collo id 
adm in istra tion, and presumably indicates an increase in 
the resistance to  blood flow  offered by the lungs.
Biochemical Estimations
Figure 45 shows the changes in fib ronectin  level. The control group 
values fe ll very s ligh tly , whereas both the E. coli and 
E. coli colloid groups showed a precip itous fa ll.  Here, as in the case 
o f pulmonary a rte ry  pressure, collo id infusion did not dim inish or 
reverse the e ffe c t o f shock. The blood lacta te  levels are shown in 
Figure 46; the control group started a t a s ligh tly  high level (2 mM) 
but fe ll steadily throughout the experim ent. The level in the 
E. coli group remained steady fo r the f irs t  four hours and then rose 
rap id ly . The E. coli colloid group also showed an increase from  four 
hours onward, but to  a lesser degree.
Indocyanine green clearance was measured in a ll groups a t the 
beginning o f the experiment and e ither a t ten hours (in the 
control group) or before death (in the case o f the E. coli and 
E. coli colloid groups). The results are shown in Table 20. In the 
control group there was no change in clearance; however, in both the 
E. coli and E. coli colloid groups clearance fe ll by about 40%. I f  
clearance can be taken as an index o f hepatic blood flow , th is  is a 
remarkable resu lt since, in the course o f the experim ent, cardiac 
output fe ll by 50% in the E. coli group but was sustained in the 
E. coli colloid group.
I t  was im portan t to  know whether th is was p rim arily  due to  a 
reduction in live r blood flow  or a reduction in hepatic ex trac tion . 
Table 21 shows the mean values fo r indocyanine green extrac tion , 
again a t the in it ia l and te rm ina l phases, fo r the control and 
E. coli colloid groups. The in it ia l extraction  ratios obtained were 
much lower than those reported fo r the healthy situation in human 
subjects. There was no s ign ifican t change in indocyanine green 
extraction  in the control group between the in it ia l and te rm ina l 
phases; however, there was a s ign ifican t fa ll in the 
E. coli colloid group. Taking the indocyanine green clearance and 
extraction  results together, i t  would appear tha t the fa ll in 
indocyanine green clearance was p rim a rily  due to  a reduction in 
extraction  ra ther than a change in hepatic blood flow . From these 
results, therefo re , one can be reasonably certa in  tha t the ex trac tion  
ra tio  changes as a result o f sepsis. Whether a change in hepatic 
blood flow  is a contribu tory  fac to r remains obscure.
Table 17
The e ffe c t o f muscle relaxants on the 
cardiovascular system o f the pig.
Heart Rate Blood Pressure Cardiac Output
Pancuronium t t t f t t
Suxamethonium t t t t
Atracurium -
j i
Vecuronium - - -
Curare 1
— = 20% change from  baseline values
t * = 20 - 50% change from  baseline values
H ( l  = 50 - 75% change from  baseline values
t t t  H I - 75% change from  baseline values
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Table 18
Mean Survival Time fo r Pig Experiments.
n
Time (hours) 
mean S.D.
C ontro l group 10 10 -
E. coli group 6 4.48 1.2
E. coli co llo id  group 10 7.42 1.25
C ontro l group v. E. co li group P >0.0001*
C ontro l group v. E. co li collo id  group P >0.0001*
. *
E. coli group v. E. co li collo id group P >  0.0001
*  Student's t  test (unpaired)
ime
ours)
1
2
3
4
3
6
7
8
9
10
Table 19
Individual Survival Times fo r Pig Experiments.
C ontro l E. co li E. co li collo id
Group Group Group
10 6 10
10 6 10
10 6 10
10 3 9
10 4 9
10 3 7
10 1 6
10 0 4
10 0 1
10 0 0
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Table 20
Indocyanine green clearance fo llow ing E.coli adm in istra tion.
8 -1The e ffe c t o f E. co li infusion (2 x 10 organisms kg" ) 
w ith  or w ithout collo id  resuscitation on porcine hepatic 
blood flow  as measured by indocyanine green clearance (ICGC)
In it ia l ICGC Term inal ICG C*
(m l m in"^) (m l m in- '*-)
n mean + S.D. n mean + S.D.
C ontro l Group • 5 379 + 40.5 5 380 + 24.5
E. co li Group ▲ 5 329 + 31.3 4 222 + 20.5
E. coli collo id  group ■ 5 346 + 34 5 200 + 25
Table o f P Values//
•  V . 0 * Not s ign ifican t
► < ►
. = 0.001
_  _ *  
■  V . ■ = 0.001
•  v. A Not s ign ifican t
•  v ‘ ■ Not s ign ifican t
■  V . ▲ Not s ign ifican t
# * v .  A * = 0.001
m *  •  v. ■ = 0.001
*  —*  A  v. ■ Not s ign ifican t
*  Term inal measurement corresponds to  10 hours in the con tro l
group and fin a l reading on both other groups.
// Student's t  test (unpaired)
Table 21
Indocyanine green extraction fo llow ing E. coli adm in istra tion.
8 -1  The e ffec ts  o f E. co li infusion (2 x 10 organisms kg~ ) w ith
collo id  resuscitation on indocyanine green extraction  (ICGE)
expressed as a ra tio  in the pig.
In it ia l ICGE Term inal ICGE*
n mean + S.D. n mean + S.D.
C ontro l group # 5 0.38 + 0.027 5 0.38 +0.29
E. coli collo id group ■ 5 0.38 + 0.031 5 0.148 + 0.024
Table o f P Values//
•  v. ■
v.
not s ign ifican t 
not s ign ifican t 
> 0.0001
*) V . • > 0.0001
*  Term inal measurement corresponds to  10 hours in the con tro l
group and fina l reading in the other group.
// Student's t  test (unpaired)
DISCUSSION
The Assay o f Plasma Fibronectin
There are several assay techniques available fo r fib ronectin : rad ia l 
im m unodiffusion, radioimmunoassay, electroimmunoassay and laser 
nephelometry, as w e ll as im m unoturb id im etry. O f these, the most 
popular have been electroimmunoassay as described by Laure ll (1966) 
and nephelometry as described by Gressner and W a llra ff (1980). Both 
are sensitive and reproducible; th e ir major lim ita tio n  is the typ ica l 24 
to  48 hour tim e delay before results are obtained. The 
im m unoturb id im etric  technique, on the other hand, can be perform ed 
in 10 to  15 m inutes. I t  was chosen in the present study because of 
the need fo r a rapid bedside assay in septic shock, where the 
physician needs in form ation about the pa tien t’s condition 
im m ediate ly. I t  has been used by other authors and been found to  
compare favourably w ith  both the Laure ll technique (Saba 1981) and 
nephelometry (Gressner and W a llra ff 1981). The main problem in its  
use, in spite o f its  popularity, has been a lack o f in fo rm ation  on its  
accuracy and precision.
The present study has shown tha t the com m ercia l 
im m unoturb id im etric  k it  (Boehringer) perform s w e ll enough to  be 
considered a useful c lin ica l tes t. However, the standard assay, as 
recommended by the m anufacturers, is not suitable fo r accurate 
measurement o f concentrations below the normal range. The 
m odifications made to  the assay at the s ta rt o f the present study 
have remedied this de fect. Consequently i t  is now possible to  assay
fib ronectin  accurate ly and precisely even when, as in septic shock, its  
concentration is substantia lly below the levels found in healthy 
subjects.
Human fib ronectin  studies
The data from  the studies o f the e ffe c t o f age and sex on plasma 
fib ronectin  levels have been discussed on Page77^8. In the study o f 
patients undergoing laparotomy (Figure 16) the finding ©f a transien t 
fa ll in fib ronectin  levels fo llow ing surgery is in agreement w ith  
published data from  other authors (Chadwick et al 1984 and Gauperaa 
et al 1985). In Gauperaa’s study the pre-operative fib ronectin  levels 
were lower than those quoted by other authors and the fa ll a fte r 
surgery more marked, perhaps because he used serum ra ther than 
plasma samples. This is like ly  to  lead to  lower fib ronectin  levels, 
because of fib ronec tin ’s high a ff in ity  fo r f ib r in . Binding to f ib r in , and 
involvement in coagulation fo llow ing surgery, may pa rtly  explain the 
fa ll in fib ronectin  observed a fte r laparotom y, but i t  may also be 
a ttribu tab le  in part to  sequestration o f fib ronectin  a t the site o f 
surgical in ju ry, brought about by its  high a ff in ity  fo r collagen (Reese 
et al 1982).
In the present study, the group o f patients who died fo llow ing 
laparotomy had s ign ifican tly  lower pre-operative fib ronectin  levels, 
and post-operatively these declined steadily (Figure 16). O'Connel e t 
al (1984) found tha t, in medical Intensive Care U n it, patients in it ia l 
fib ronectin  levels were s ign ifican tly  lower in patients who 
subsequently died than in patients who survived to  leave the u n it; and 
Richards et al (1983) reported tha t patients who developed s ign ifican t
in tra-abdom inal in fection  and m ultip le  organ fa ilu re  post-operative ly 
had s ign ifican tly  lower fib ronectin  levels pre-operative ly than 
patients who did not develop com plications. In our laparotom y study, 
however, the d ifference in fib ronectin  levels between survivors and 
non survivors, w h ils t s ta tis tica lly  s ign ifican t, was in su ffic ie n t to 
allow  any discrim ination on the basis o f fib ronectin  levels alone.
In the present study o f patients w ith  sepsis but not in shock i t  was 
found tha t fib ronectin  levels fe ll,  and remained low, in non-survivors 
(Figure 18), but returned towards normal in survivors (Figure 19). 
Most, but not a ll, other authors agree w ith  th is find ing; th is  w ill be 
discussed in more de ta il on Page170. K lim  et al (1986) have recen tly  
examined various coagulation factors in surgical Intensive Care U n it 
patients, in an a ttem pt to  distinguish between septic and non-septic 
patients. They found tha t by measuring fibrinogen, p a rtia l 
thromboplastin tim e, plasminogen and fib ronectin , then using rank 
discrim inant analysis i t  was possible to  discrim inate between septic 
and non-septic patients. F ibronectin level was the most im portan t 
single variable fo r c lassifica tion, and fib ronectin  level alone 
co rrec tly  predicted the outcome in 90% o f patients in th e ir study. 
They concluded tha t measurement o f fib ronectin  should become 
routine fo r patients in a surgical Intensive Care U n it.
Septic Shock Study
The APACHE II and Sepsis Scoring systems were applied to  a ll 
patients at the tim e o f admission to the septic shock study. The 
APACHE II score is a powerfu l method in assessing prognosis and has 
been w idely adopted fo r use in intensive care (Knaus et al 1981, Bion
et al 1985). The Sepsis Score is more specifica lly  fo r  grading the 
severity o f sepsis and in th is study, when combined w ith  the APACHE 
II score i t  provided a useful means o f assessing the com parab ility  o f 
patient groups. For the contro l and cryoprecip ita te  groups the mean 
APACHE II scores were respective ly 19.3 and 21.5 and the mean 
sepsis scores 21.5 and 22. (Table 7). These scores show th a t the tw o 
groups were w e ll matched and underline the severity o f illness in 
these patients. A ll other variables examined (age, blood pressure, 
a rte rio-aveolar oxygen gradient, plasma fib ronectin  and indocyanine 
green clearance) also show tha t the two groups were w e ll matched.
A ll patients had low fib ronectin  levels at the tim e o f admission to  the 
study, and in the contro l patients consistently low or steadily fa lling  
levels were associated w ith  a fa ta l outcome. In patients receiving 
cryoprec ip ita te , plasma fib ronectin  was elevated by an average o f 
135 mg 1"^ per pool o f 10 units o f cryoprec ip ita te  infused. During 
the ir f irs t  24 hours in Intensive Care, patients often had to  be given 
cryoprecip ita te  two or three tim es but, as they stabilised, i t  usually 
became possible to  p red ict from  consecutive plasma fib ronectin  
estimations what th e ir requirem ent would be. This usually allowed 
cryoprec ip ita te  to  be given only once a day. C ryoprecip ita te  infusion 
had a s ign ifican t e ffe c t on a varie ty  o f physiological variables: urine 
output; core tem perature; endotoxin and plasma fib ronectin  (Table 9). 
However, i t  was not fo llowed by an increase in cardiac output or 
pulmonary arte ry wedge pressure, suggesting tha t the benefic ia l 
e ffec ts  were non-a ttributab le  to volume expansion. An a lte rna tive , 
more a ttra c tive , hypothesis would be tha t the fib ronectin , (or some 
other protein in the cryoprecip ita te ), is s tim ula ting clearance o f 
endotoxin by the re ticu loendothe lia l system; and tha t the o ther
benefic ia l e ffec ts  are a consequence o f lower plasma endotoxin 
levels.
The overall m o rta lity  ra te  was lower in cryop rec ip ita te -trea ted  
patients than in contro l patients (7/12 vs 9/11). Early m o rta lity  was 
lower in the c ryoprec ip ita te -trea ted  group w ith  a s ta tis tic a lly  
s ign ifican t d iffe rence in m o rta lity  rates on day 2 and day 3 fo llow ing 
admission to  the study (Figure 25). There have been re la tive ly  few 
contro lled studies o f cryoprec ip ita te  therapy in septic shock patients, 
and, in general, other authors' experiences in this fie ld  have been 
disappointing (Hesselvik et al 1986, Thijs, personal com munication). 
There is, however, a m ajor d iffe rence between the procedure 
followed in our study and tha t adopted by Hesselvik et a l, in th a t they 
gave cryoprec ip ita te  to  th e ir patients only on day 1 and day 2. As 
can be seen from  the patient p ro file  shown in Figures 20 to  24, 
plasma fib ronectin  levels rap id ly fa ll back to  a sub-normal range 
a fte r the infusion o f c ryoprec ip ita te , especially when the degree o f 
sepsis is severe and the patients are unstable. Saba et al (1984) 
observed in th e ir study o f cryoprecip ita te  adm in istration to  patients 
who had suffered in jury tha t the reversal o f fib ronectin  defic iency 
a fte r infusion o f cryoprecip ita te  was more sustained in non-septic 
patients than in septic patients. This is in keeping w ith  our own 
observations, and suggests tha t fib ronectin  is more rapid ly removed 
from  the blood stream in severe sepsis. From the patien t pro files  
(Figures 20 to  24) i t  would appear tha t the ra te  o f th is rem oval 
decreases as the patient's condition improves. The reasons fo r  th is 
"consumption" w ill be discussed la te r on Page172.
In summary, the c lin ica l observations in th is study have shown:
(1) the im m unoturb id im etric  technique is an appropriate 
assay fo r use in a study o f fib ronectin  replacem ent;
(2) Plasma fib ronectin  levels are:-
higher in the elderly than in the population at large 
transien tly  decreased fo llow ing surgery 
decreased by sepsis
(3) Plasma fib ronectin  levels are very low in septic shock;
(4) In patients in septic shock, cryoprecip ita te  infusion 
elevates plasma fib ronectin  and can be used to  m ainta in 
a normal plasma fib ronectin  leve l; i t  has benefic ia l 
e ffec ts  on endotoxin levels, urine output and core 
tem perature;
(5) M o rta lity  from  septic shock may be reduced by 
cryoprecip ita te  therapy.
The Rat Experiments
Patients in septic shock receive an overwhelming varie ty  o f drugs, 
most o f which are metabolised in the live r by the cytochromeP450 
system (Estabrook et al 1978). I t  seemed o f in te rest, there fo re , to 
include in the c lin ica l study measurements o f the a c tiv ity  o f th is 
system. This was done by determ ining antipyrine clearance. In a ll 
the patients th is proved to be abnormally slow (average h a lf- life  o f 
28.7 hours whereas the accepted healthy value is 10 hours). I t  was 
im portant to  establish i f  th is re flec ted  damage to the cytochrome 
P450 system o f the patient's live r. There are plausible a lte rna tive  
explanations. Conceivably th is system was so busy metabolising the 
other drugs given to  the patient tha t i t  had no tim e to  deal w ith  the 
antipyrine. I t  could be tha t sepsis impaired antipyrine uptake ra ther 
than antipyrine metabolism . The ra t experiments showed th a t, 
provided su ffic ien t doses o f endotoxin were given, the cytochrome P 
450 system was indeed damaged; tha t th is damage was greatest in the 
case o f cytochrome P450 its e lf; and tha t no comparable e ffe c t was 
produced by haemorrhagic shock. Moreover the extent o f the 
im pairm ent (about 70%) would be su ffic ien t to explain the magnitude 
o f the increase in antipyrine h a lf- life  seen in septic shock patients 
(PagelOO).
As pointed out by W erringloer (1982), even small changes in 
cytochrome b5 or in the cytochrome c reductases could have a m ajor 
e ffe c t, since they may be the ra te  lim itin g  enzymes fo r 
mono-oxygenase reactions. Endotoxin is know to  bind strongly to  any 
ce ll membrane through its  lip id  A. Once w ith in  the ce ll, its  sites o f
attachm ent and a ttack  are less w e ll known. Schumer e t al (1970) and 
Silver (1981) have shown tha t the membrane o f endoplasmic 
re ticu lum  was disrupted in ra t live r a fte r exposure to  endotoxin. This 
may explain the finding in the present study tha t cytochrome P450 
a c tiv ity  was more a ffected  than the a c tiv ity  o f the other enzymes, 
since it  is highly hydrophobic and is an in tegra l protein w ith in  the 
membrane o f endoplasmic re ticu lum  (Ito et al 1968). Cytochrom e b5, 
NADPH cytochrome c reductase and NADH cytochrome c reductase, 
on the other hand, have large hydrophilic components, are less 
membrane-bound, and m ight therefore be expected to  be less 
a ffected  by endotoxin.
Other authors have looked at the e ffe c t o f endotoxin on m icrosomal 
cytochrome a c tiv ity , but the e ffec ts  o f a wide range o f doses o f 
endotoxin have not been studied nor have the haemodynamic and 
m etabolic e ffec ts  o f endotoxin been separated. Falzon et al (1984) 
reported tha t, fo llow ing in traperitoneal endotoxin, cytochrome P450 
a c tiv ity  fe ll to  60% o f the contro l leve l, cytochrome b5 a c t iv ity  fe ll 
to  80% o f the con tro l leve l, NADH cytochrome c reductase also fe ll 
to  80%, while NADPH c reductase fe ll to  60%. In te resting ly , when 
the dose o f endotoxin administered was increaed from  3.5 mg kg"'*' to  
6 mg kg” \  the inh ib ition o f cytochrome a c tiv ity  was less marked, in 
contrast to  the results in th is study where a clear dose response was 
discernible over a wide range o f doses o f endotoxin. Bissell and 
Hammaker (1976) reported tha t, a fte r the in traperitonea l in jec tion  o f 
1.5 mg kg"'*' o f salmonella endotoxin, cytochrome P450 a c t iv ity  was 
decreased. There was l i t t le  e ffe c t at five  hours, but by 22 hours 
cytochrome P450 a c tiv ity  was reduced by ha lf. The marked 
inh ib ition  o f the cytochrome P450 system a fte r endotoxin
adm in istra tion obviously has im portant im plications in the c lin ica l 
fie ld , since many o f the drugs administered to  patients in septic 
shock are metabolised by i t .  The fa c t tha t inh ib ition  is produced by a 
dose o f endotoxin 100 tim es less than tha t needed to bring about a 
fa ll in blood pressure is also im portant. I t  im plies, i f  i t  can be 
extrapolated to the c lin ica l s itua tion , tha t by the tim e septic shock is 
signalised by hypotension, the patient w ill already have suffered 
serious im pairments o f a t least one function o f the live r.
The Pig Experiments
Many animal models o f septic shock have been described in the 
lite ra tu re , and a varie ty  o f species have been used. They have been 
subjected to  infusion o f endotoxin or live  Escherichia co li or to  such 
procedures as caecal liga tion . They have followed a variey o f tim e  
courses, and they have, not surprisingly, led to  a va rie ty  o f 
haemodynamic results.
In th is study the aim was to  examine the e ffe c t o f septic shock on 
live r function . I t  was convenient to  use an animal tha t was not too 
d iffe re n t from  man and to  adopt an experim ental design which would 
extend over a su ffic ien t tim e to allow any change in live r function  to  
develop, yet be short enough to  allow  the animal to  be kept under 
anaesthesia throughout. I t  is w e ll recognised tha t dogs respond to  
endotoxaemia w ith  sudden systemic a rte ria l hypotension, probably as 
a result o f venous pooling o f blood in the splanchnic c ircu la tion . This 
is now ascribed to  a functiona l hepatic venous ou tflow  sphincter 
(Hinshaw et al 1966). This appeared to  rule out the use o f dogs; the 
pig was the obvious a lte rna tive .
As techniques fo r inducing sepsis, caecal or appendiceal liga tion  were 
excluded fo r two reasons: f ir s t,  they are so slow to take e ffe c t th a t 
the animal has to  be allowed to  recover consciousness before sepsis 
develops, and is therefore unprotected from  the distress i t  occasions; 
and secondly, because the haemodynamic e ffec ts  are very variable 
(Nxumulo et al 1978 and Gappos et al 1982). Endotoxin has obvious 
advantages in term s o f rep roduc ib ility  o f dose and there fo re  o f 
e ffec ts  but in the case o f 20 to  30 kg animals is p roh ib itive ly  
expensive. Hence the decision to  infuse live  Escherichia c o li. To 
fa c ilita te  comparison w ith  the c lin ica l s ituation, three groups o f pigs 
were studied:-
(1) C on tro l group
cannulated and maintained under anaesthesia but 
otherwise in ta c t;
(2) E. co li group
cannulated, maintained under anaesthesia and infused 
w ith  live bacteria . This group was intended to  
represent the pa tien t in septic shock and untreated;
(3) E. co li co llo id  group
cannulated, maintained under anaesthesia and infused 
w ith  live bacteria , and also given su ffic ie n t co llo id  to  
m aintain its  pulmonary a rte ry  wedge pressure. This 
group was intended to represent the patient in septic 
shock given, as would norm ally be the case, s u ffic ie n t 
collo id to  m aintain blood volume.
The con tro l group's importance lies in the fa c t tha t i t  demonstrates 
tha t throughout the 10 hours o f the experiment pulse, blood pressure,
cardiac output and pulmonary a rte ry  wedge pressure remain 
essentially constant. The E. coli group shows what m ight be expected 
in a patient in septic shock who received no trea tm en t. The pulse 
ra te  rises sharply, the blood pressure fa lls  less precip itiously but over 
a longer period and the cardiac output fa lls  gradually. The pulmonary 
a rte ry  wedge pressure (more succinctly, the le f t  a tr ia l pressure) is 
in it ia lly  maintained but, a fte r some hours, declines also. These are 
the typ ica l features o f hypodynamic shock as seen by the c lin ic ian . 
In the E. coli colloid group there was again an increased pulse ra te , 
but the increase was less than tha t seen when collo id was not given. 
The blood pressure was maintained fo r longer than in the absence of 
co llo id . The cardiac output rose substantia lly, was sustained fo r 
some hours at th is higher level, but u ltim a te ly  declined to  about the 
in it ia l leve l. These m anifestations are rem iniscent o f the 
hypodynamic phase o f septic shock as seen by the c lin ic ian . The 
plasma lacta te  results indicate the degree o f m ic roc ircu la to ry  
hypoperfusion th a t was present in the group o f pigs receiving 
E. coli colloid, despite the hyperdynamic p icture  w ith  a high cardiac 
output and normal blood pressure; the lacta te  values remained low 
and w ith in  the normal range in the control group while both E. coli 
and E. coli colloid groups showed a s ign ifican t and marked rise in 
lacta te  levels.
L iver Function in Septic Shock
M ultip le  organ fa ilu re  is common in c r it ic a lly  i l l  patients suffering 
from  septic shock and is a frequent cause o f death in such patients. 
There is often no obvious sign o f hepatic im pairm ent, and a tten tion  
and therapeutic e ffo r t  are usually focused on other organs, 
pa rticu la rly  the lungs, kidneys and heart, since fa ilu re  o f these 
produces more obvious c lin ica l signs. Fine (1954) suggested th a t the 
liv e r m ight be the prim ary ta rge t organ in patients suffering from  
shock, but this suggestion has not been w idely followed up, perhaps 
because the standard liv e r function tests have been in su ffic ie n tly  
sensitive to evaluate the degree o f hepatic im pairm ent (Ledingham 
1985). In a retrospective study, Banks et al (1982) examined liv e r 
function tests in a group o f 57 patients w ith  septic shock, 27 o f whom 
survived to  leave Intensive Care. L ive r tests w ith in  48 hours o f the 
diagnosis o f septic shock showed marked but variable live r damage. 
The results obtained from  patients who survived were not 
s ign ifican tly  d iffe re n t from  those obtained fo r patients who died. 
L ive r function tests, w ith  the exception o f b ilirub in , fa iled  to  
distinguish between survivors and non-survivors. Banks' study 
underlined the fa c t tha t, while there is considerable hepatic 
im pairm ent in patients suffering from  septic shock, the available 
tests o f live r function are inadequate to  allow  any pred iction o f the 
outcome to  be made during the early course o f trea tm en t. There was 
therefore a need to  assess a lte rna tive  techniques o f measuring the 
degree o f hepatic im pairm ent. I t  was fo r th is reason th a t in the 
study o f c lin ica l septic shock, both indocyanine green clearance from  
plasma and antipyrine h a lf- life  were calculated in a ll patients
(Figures 10 and 11). Indocyanine green clearance has custom arily 
been used as an index o f hepatic blood flow  (Feely et al 1981) and 
antipyrine ha lf l i fe  as an index o f the a c tiv ity  o f the cytochrome 
P450 system o f the live r (Boobis et a l 1981).
In the c lin ica l septic shock study, in it ia l values o f indocyanine green 
clearance were very low in a ll patients (Table 10). There was no 
s ign ifican t d iffe rence between patients who subsequently survived 
and those who did not. The trend in indocyanine green clearance over 
the f ir s t  24 hours does however appear to  be o f prognostic value. 
Over th is period there is a s ign ifican t change in indocyanine green 
clearance indocyanine green clearance can change dram atica lly  over 
an even shorter tim e course (i.e. before or a fte r c ryoprec ip ita te  
infusion). "S ta tic " live r function tests, such as b ilirub in  leve l, tend to  
change much more slow ly; th is is presumably because indocyanine 
green clearance is p a rtly , perhaps predom inantly, dependent on 
hepatic’v blood flow , which can change rap id ly . The levels o f 
indocyanine green clearance seen in septic shock patients were o ften 
so low tha t i t  seems improbable tha t they could be approxim ations o f 
hepatic blood flow  (since such low blood flows would resu lt in massive 
necrosis o f both the gut and the live r). I t  seems more like ly  th a t the 
extraction  o f indocyanine green was decreased in these patients, but 
to  measure th is i t  would have been necessary to insert a catheter in to  
the hepatic vein. I t  was fo r th is reason tha t fu rthe r studies in to  the 
handling o f indocyanine .green by the live r were carried out in the pig. 
These showed tha t infusion o f Escherichia co li brought about a 40% 
fa ll in indocyanine green clearance, regardless o f whether co llo id  was 
administered or not. The fa c t tha t collo id  adm in istra tion had no 
e ffe c t on the ra te  o f clearance is suprising in view o f the fa c t th a t i t
greatly  increased cardiac output. This is, at the least, an indication 
tha t the im pairm ent o f clearance is not due to hypovolaemia. There 
is a para lle l here w ith  the im pairm ent o f cytochrome P450 function 
seen in rats infused w ith  endotoxin (Figure 34).
The hypothesis tha t septic shock reduces the liver's a b ility  to  e x tra c t 
indocyanine green from  the blood passing through i t  would also 
explain, in part a t least, the fa c t tha t, although collo id  
adm in istration greatly  improved cardiac output in pigs infused w ith  
Escherichia c o li, i t  produced no im provement whatever in 
indocyanine green clearance. It  was obviously desirable to  determ ine 
d ire c tly  the proportion o f indocyanine green extracted from  the blood 
as i t  passed through the live r. This is however easier said than done, 
since, in the pig, the only way to  sample blood leaving the liv e r is to 
occlude tem porarily  the posterior vena cava below the level o f the 
live r and to  w ithdraw  the blood sample above the occlusion. This 
procedure is feasible, though not easy, in a healthy anim al; in an 
animal in shock i t  is liable to  provoke cardiac arrest. Such results as 
could be obtained, however, suggested th a t, even in the healthy 
animal, the proportion o f indocyanine green extracted in passage 
through the live r was only 38% and tha t in septic shock i t  was 
reduced to  15%.
Just as indocyanine green clearance was retarded by a fa c to r o f 2 in 
septic shock, so also was antipyrine clearance. The compounds are 
both disposed o f by the live r, but by quite d iffe re n t processes: 
indocyanine green is conjugated and secreted in the bile ; antipyrine is 
oxidised by the cytochrome P450 system. I t  is possible th a t in septic 
shock a single mechanism is responsible fo r the im pairm ent o f both
processes. Reduction in hepatic blood flow  is a possib ility ; but i t  has 
been shown above tha t this is probably not the main fa c to r in the 
case o f indocyanine green. Again, i t  is conceivable tha t the defect 
lies in the uptake o f both compounds in to the ce ll ra ther than th e ir  
metabolism once inside, but i t  seems unlike ly tha t two compounds 
w ith  such very d iffe re n t structures and w ith  such d iffe re n t ha lf-lives  
(in normal subjects, 3 minutes fo r indocyanine green, 10 hours fo r 
antipyrine) should share a common means o f entry in to  the 
hepatocytes. I t  seems much more reasonable to  suppose th a t the 
depression o f the cytochome system produced by endotoxin infusion 
in rats is paralleled by a s im ila r depression in patients in septic shock 
and tha t th is is su ffic ie n t to account fo r th e ir in a b ility  to  clear 
antipyrine.
Fibronectin
The lite ra tu re  contains con flic ting  reports on the e ffe c t o f sepsis on 
plasma fib ronectin  levels. Some authors have reported a rise in the 
early stages (up to  24 hours) o f sepsis induced in animals by 
in traperitonea l in jection o f bacteria  (Lanser e t al 1982 and 1983, 
Aukburg et al 1981). In contrast, a ll the c lin ica l studies, w ith  one 
exception (Stathakis 1981) have shown tha t plasma fib ronectin  is 
lower in patients w ith  sepsis than in those w ithou t (Rubli e t al 1983, 
K lim  et al 1986, Boughton et al 1982). This fa ll appears to  be most 
marked in c r it ic a lly  i l l  patients w ith  severe sepsis, especially i f  they 
have disseminated in travascular coagulation (Chadwick e t a l 1984, 
O'Connell e t al 1984). These reports are in agreement w ith  the work 
described in the present study.
The published animal results, however, w ith  reports o f rising 
fib ronectin  levels in the f irs t  24 hours a fte r in traperitonea l in jection  
o f bacteria , are in contrad iction w ith  the pig experiments in the 
present study (Page 151) in which fib ronectin  levels fe ll d ram atica lly  
w ith in  two hours o f the infusion o f Escherichia co li being sta rted . 
This discrepancy can plausibly be explained by two considerations:
(1) I t  seems unlike ly tha t severe sepsis would develop 
w ith in  24 hours o f in traperitonea l innoculation w ith  
bacteria , which was the technique used by Lanser e t al 
(1982) and Aukburg et al (1981); whereas intravenous 
innoculation, as used in the present study, m ight be 
expected to e lic it  an im m ediate response. I t  is w e ll 
known tha t severe sepsis is associated w ith
disseminated intravascular coagulation, and this in 
its e lf can reduce fib ronectin  levels.
(2) The rise in fib ronectin  fo llow ing in traperitonea l 
innoculation o f bacteria m ight w e ll be due to the stress 
which would fo llow  such a procedure. Owens and
T -
Cimino (1982) have shown tha t stress hormones such as 
cortiso l increase hepatic synthesis o f fib ronec tin .
I t  seems therefore safe to  conclude tha t sepsis lowers plasma 
fib ronectin  levels in experim ental animals as w e ll as patients. The 
low levels o f fib ronectin  observed in sepsis could be due to  one or 
more o f the fo llow ing: increased in travascular consumption;
decreased synthesis; or increased extravascular d is tribu tion . I t  has 
been reported tha t fib ronectin  is taken up by tissues a t the s ite of 
in jury or surgical trauma (Reese et a l 1982) as a result o f binding to 
exposed collagen. This may explain the fa ll in fib ronectin  fo llow ing 
surgery, but not the much greater reductions in fib ronectin  level 
observed in sepsis. Severe sepsis, w ith  its  associated increase in 
cap illa ry perm eability , is like ly  to increase leakage o f fib ronectin  
in to  the extravascular space. I t  has been shown to  increase leakage 
o f albumin to the extravascular space up to th ree-fo ld  (Fleck e t al 
1985), but since fib ronectin  is a much larger m olecular weight than 
albumin (molecular weight 440,000 vs 69,000), i t  m ight be less 
a ffec ted  by this perm eability  change. In patients w ith  severe sepsis 
o f long standing (i.e. more than 48 hours) w ith  im pairm ent o f organ 
function, decreased synthesis o f fib ronectin  is like ly  to  be a 
contribu tory fa c to r (Pussell et al 1985). These mechanisms by 
themselves seem inadequate to  account fo r the precip itous fa ll 
observed in fib ronectin  level in the pigs in septic shock in the present
study. Increased consumption by some mechanism seems a more 
like ly  explanation. This consumption may be due to fib ronectin  being 
involved in opsonisation o f c ircu la ting  endotoxin and other bacteria l 
ce ll w a ll debris, w ith  subsequent clearance by the re ticu loendothe lia l 
system. F ibronectin levels in septic patients are even lower when 
there is associated disseminated intravascular coagulation. In the 
pig, such coagulation does occur in sepsis induced by the technique 
used in the present work (Ramsay 1986, a p riva te  com munication). I t  
has been suggested tha t f ib r in  m icro-aggregates are opsonised by 
plasma fib ronectin  and cleared by the re ticu loendothe lia l system. 
Powell et al (1986) have shown tha t in patients who had undergone 
ao rtic  surgery there was a post-operative fa ll in fib ronectin  level 
which was due to  consumption o f fib ronectin  in the fo rm ation  o f 
complexes w ith  c ircu la ting  collagen debris. This was found to an 
even more marked degree in pigs subjected to  prolonged ao rtic  cross 
clamping.
I t  would seem therefore tha t, in septic shock, fib ronectin , as w e ll as 
leaking out through the cap illa ry w a ll, may be taken up:-
(1) In the opsonisation o f endotoxin and bacteria l debris
(2) In the opsonisation o f f ib r in  in in travascular coagulation
(3) In form ation o f complexes w ith  the breakdown products 
o f collagen.
Endotoxaemia in Septic Shock
I t  has long been recognised tha t \n  experim ental animals an in jected 
dose o f endotoxin is rap id ly cleared by the re ticu loendothe lia l 
system, in which the K up ffe r cells o f the liv e r are num erica lly 
preponderant. The processes o f clearing the endotoxin its e lf and the 
fib r in  degradation products from  the disseminated in travascular 
coagulation i t  provokes, e ffe c tive ly  saturate the re ticu loendothe lia l 
system. The consequence is tha t a second dose, in jected before the 
f irs t  is com plete ly disposed o f, is cleared very slow ly, so slowly tha t 
i t  may persist long enough to  cause serious organ damage and 
u ltim a te ly  death. This so-called "Schwartzman phenomenon" 
demonstrates both the e fficacy  o f the re ticu loendothe lia l systems in 
dealing w ith  a lim ite d  amount o f endotoxin and the dire consequences 
when its  capacities are exceeded.
There is some reason to  believe tha t endotoxin may be present in the 
po rta l blood o f normal healthy individuals. I t  is known th a t 
obstructive jaundice impairs the function o f the re ticu loendothe lia l 
system. Further C ahill (1983) has shown tha t obstructive jaundice 
increases the like lihood o f substantial porta l endotoxaemia, 
sometimes accompanied by systemic endotoxaemia. Taken together, 
these observations suggest tha t in normal healthy individuals there is 
some passage o f endotoxin from  Gram-negative organisms in the gut 
in to  the in testina l capillaries and thence to  the porta l c ircu la tion . 
This is norm ally in tercepted by the K up ffe r cells. I f ,  however, 
K up ffe r ce ll a c tiv ity  is depressed (e.g. by obstructive jaundice) some 
endotoxin may escape in terception, pass in to the systemic c ircu la tion
and, once there, cause organ fa ilu re  (e.g. the renal fa ilu re  sometimes 
seen in patients w ith  obstructive jaundice). I t  has been shown, both 
in experim ental animals and in patients, tha t cholestatic jaundice can 
indeed lead to  the development o f septic shock. (Pain et a l 1985).
Furtherm ore, a ll patients in shock, whatever its  cause, w ill a t least in 
the early stages, have a substantia lly diminished blood flow  through 
the gut and the live r, and an increased mucosal perm eab ility  in the 
fo rm er. These factors m ight simultaneously favour leakage o f 
endotoxin from  the gut to  the porta l blood, and hinder its  rem oval by 
the K upffe r cells. In th is connection i t  is notable tha t patients who 
have been diagnosed as in septic shock on the basis o f c lin ica l c r ite r ia  
are almost invariably found to have systemic endotoxaemia, although 
in many cases they have negative blood cultures. In the present 
study, endotoxaemia was detected at some stage in a ll patients. In 
pa rticu la r, high endotoxin levels were detected in two patients w ith  
Gram -positive septicaemia (the case histories o f these patients T.B. 
and Q.E. are given on Page104). Gram -positive organisms do not 
have endotoxin in th e ir ce ll walls and neither o f these patients a t any 
stage gave positive cultures fo r Gram-negative organisms. I t  seems 
inescapable tha t th e ir endotoxin must have been coming from  
bacteria  in the gut.
I f  i t  is true th a t, in general, patients w ith  septic shock have 
endotoxaemia, and tha t the endotoxin is derived from  the patients 
own in testina l flo ra , i t  m ight be sensible to  tre a t the condition by 
measures aimed at reducing levels o f c ircu la ting  endotoxin. In the 
present study, cryoprecip ita te  was shown to  bring about th is resu lt: 
the other benefic ia l changes which i t  produces may be secondary to  
th is reduction in endotoxin level.
CONCLUSIONS
The nature o f shock is a complex subject in which generalisation is 
hazardous, and the fo llow ing views are put forward w ith  due 
d iffidence.
1 I t  is generally agreed tha t in a ll form s o f shock splanchnic 
blood flow  is depressed and perm eability  o f the in testina l 
mucosa increased. I t  seems reasonable to  suppose tha t such 
circumstances would favour passage o f endotoxin from  the gut 
to  the porta l blood and im pair the a b ility  o f the K u p ffe r cells 
to  in te rcep t it .
2 The c lin ica l part o f the present study has shown tha t
endotoxaemia is an invariable feature o f septic shock, even 
when the cause o f the condition is in fection  w ith  organisms 
which do not produce endotoxin; and tha t endotoxaemia in
such cases is often not accompanied by detectable
septicaem ia. It  seems reasonable, there fo re , to  suppose th a t
septic shock is, in general, due to  escape o f endotoxin from  
the gut in quantities too great to  be in tercepted by the 
K up ffe r cells o f the live r.
3 In the course o f the c lin ica l part o f th is study i t  was noted
tha t hepatocyte function , as re flec ted  in clearance o f 
indocyanine green and antipyrine, was greatly  im paired. The 
evidence o f the ra t and pig experiments indicates tha t in both 
cases this was a d irec t e ffe c t o f high c ircu la ting  levels o f 
endotoxin (and thus not re lated to the state o f the K u p ffe r
cells). I t  may simply exem plify the damage endotoxin in flic ts  
on a wide varie ty  o f organs and tissues.
I f  the views outlined in paragraphs 1 and 2 above are co rrec t, 
i t  may be im portant in septic shock to try  to  reduce the 
endotoxaemia. In the present study i t  was found tha t th is 
could be achieved by cryoprec ip ita te  adm in istra tion. The 
reduction in endotoxin levels was accompanied by 
improvements in urine output, and core tem perature and there 
was also some evidence tha t survival was prolonged.
I t  would seem, there fo re , tha t regular endotoxin assays, 
preferably at in tervals as b rie f as every four hours, may be a 
useful means o f m onitoring the condition o f septic shock 
patients, and tha t cryoprec ip ita te  therapy may have a pa rt to  
play in the ir trea tm ent.
The m o rta lity  ra te  in patients suffering from  shock depends to  
a large extent on the underlying cause; patients w ith  
uncomplicated hypovolaemic shock, i f  trea ted early, have a 
very good prognosis, while septic shock, especially i f  the 
diagnosis and trea tm ent are delayed, has an extrem ely poor 
one. The m o rta lity  from  septic shock has remained unchanged 
fo r many years, despite m ajor advances in surgical techniques 
and technological medicine. Therefore i t  could be argued th a t 
any therapeutic manoeuvre which has any in fluence on 
m o rta lity  in septic shock, or even buys tim e  fo r o ther 
treatm ents (such as surgery and antib io tics) to  be successful, 
could be considered a s ign ifican t advance in the management 
o f patients w ith  septic shock.
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